: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Influenza

Free Subscription

Articles published in N Engl J Med
Retrieve available abstracts of 805 articles:
HTML format

Single Articles

April 2024

GANDHI RT, Hirsch M
Treating Acute Covid-19 - Final Chapters Still Unwritten.
N Engl J Med. 2024;390:1234-1236.
PubMed

HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
N Engl J Med. 2024;390:1186-1195.
PubMed Abstract available

March 2024

HSIAO A, Fireman B, Klein NP
Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply.
N Engl J Med. 2024;390:1156.
PubMed

WOO EJ, Hulse AN
Recombinant Influenza Vaccine in Adults under 65 Years of Age.
N Engl J Med. 2024;390:1155-1156.
PubMed

HAVIARI S, Massonnaud CR, Dupont A
Recombinant Influenza Vaccine in Adults under 65 Years of Age.
N Engl J Med. 2024;390:1155.
PubMed

DIEUSSAERT I, Hyung Kim J, Luik S, Seidl C, et al
RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.
N Engl J Med. 2024;390:1009-1021.
PubMed Abstract available

February 2024

ELLINGJORD-DALE M, Brunvoll SH, Soraas A
Prospective Memory Assessment before and after Covid-19.
N Engl J Med. 2024;390:863-865.
PubMed

AL-ALY Z, Rosen CJ
Long Covid and Impaired Cognition - More Evidence and More Work to Do.
N Engl J Med. 2024;390:858-860.
PubMed

HAMPSHIRE A, Azor A, Atchison C, Trender W, et al
Cognition and Memory after Covid-19 in a Large Community Sample.
N Engl J Med. 2024;390:806-818.
PubMed Abstract available

MONTO AS, Zambon M, Weir JP
The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.
N Engl J Med. 2024 Feb 28. doi: 10.1056/NEJMp2314801.
PubMed

BENEZECH S, Khoryati L, Belot A
More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C. Reply.
N Engl J Med. 2024;390:771-772.
PubMed

FRANCO A, Tremoulet A, Burns JC
More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C.
N Engl J Med. 2024;390:771.
PubMed

HERBERT C, McManus DD, Soni A
Persistent False Positive Covid-19 Rapid Antigen Tests.
N Engl J Med. 2024;390:764-765.
PubMed

January 2024

MISSET B, Desmecht D, Laterre PF
Convalescent Plasma for Covid-19-Induced ARDS. Reply.
N Engl J Med. 2024;390:386.
PubMed

CASADEVALL A, Shoham S, Pirofski LA
Convalescent Plasma for Covid-19-Induced ARDS.
N Engl J Med. 2024;390:385-386.
PubMed

SENEFELD JW, Henderson JP, Joyner MJ
Convalescent Plasma for Covid-19-Induced ARDS.
N Engl J Med. 2024;390:385.
PubMed

BORGHESI A, Casanova JL
Convalescent Plasma for Covid-19-Induced ARDS.
N Engl J Med. 2024;390:384-385.
PubMed

CAO B, Wang Y, Lu H, Huang C, et al
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
N Engl J Med. 2024;390:230-241.
PubMed Abstract available

December 2023

HALASA NB
RSV Prevention - Breakthroughs and Challenges.
N Engl J Med. 2023;389:2480-2481.
PubMed

DRYSDALE SB, Cathie K, Flamein F, Knuf M, et al
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.
N Engl J Med. 2023;389:2425-2435.
PubMed Abstract available

Covid Update: ITT Episode 23.
N Engl J Med. 2023;389:e52.
PubMed

HSIAO A, Yee A, Fireman B, Hansen J, et al
Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age.
N Engl J Med. 2023;389:2245-2255.
PubMed Abstract available

COHN AC, Hall AJ
Continued Progress in the Development of Safe and Effective RSV Immunizations.
N Engl J Med. 2023;389:2289-2290.
PubMed

WILSON E, Goswami J, Baqui AH, Doreski PA, et al
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
N Engl J Med. 2023;389:2233-2244.
PubMed Abstract available

November 2023

BENEZECH S, Khoryati L, Cognard J, Netea SA, et al
Pre-Covid-19, SARS-CoV-2-Negative Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2023;389:2105-2107.
PubMed

WANG Y, Guo Z, Ye B, Liu L, et al
Association of SARS-CoV-2 Infection during Early Weeks of Gestation with Situs Inversus.
N Engl J Med. 2023;389:1722-1724.
PubMed

October 2023

MISSET B, Piagnerelli M, Hoste E, Dardenne N, et al
Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients.
N Engl J Med. 2023;389:1590-1600.
PubMed Abstract available

BLADH O, Greilert-Norin N, Havervall S, Marking U, et al
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.
N Engl J Med. 2023;389:1626-1628.
PubMed

HILLS TE, Lorenzi E, Berry LR, Shyamsundar M, et al
Simvastatin in Critically Ill Patients with Covid-19.
N Engl J Med. 2023 Oct 25. doi: 10.1056/NEJMoa2309995.
PubMed Abstract available

The Long Haul of Long Covid.
N Engl J Med. 2023;389:e29.
PubMed

ABI-RACHED JM, Brandt AM
Do Pandemics Ever End?
N Engl J Med. 2023;389:1349-1351.
PubMed

September 2023

BOULWARE DR, Lindsell CJ, Stewart TG, Hernandez AF, et al
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
N Engl J Med. 2023;389:1085-1095.
PubMed Abstract available

August 2023

MURRAY EJ, Cowger TL, Hall KT
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff. Reply.
N Engl J Med. 2023;389:580.
PubMed

MARINE JE
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:579.
PubMed

LADHANI SN, Andrews N, Ramsay ME
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:579.
PubMed

RUSSELL FM, Curtis N, Carlin J
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:578-579.
PubMed

KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al
SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
N Engl J Med. 2023;389:474-475.
PubMed

July 2023

BECERRA X, Jha A
Project NextGen - Defeating SARS-CoV-2 and Preparing for the Next Pandemic.
N Engl J Med. 2023 Jul 26. doi: 10.1056/NEJMp2307867.
PubMed

ARBEL R, Sergienko R, Netzer D, Hammerman A, et al
Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19. Reply.
N Engl J Med. 2023;389:285-286.
PubMed

HOEG TB, Duriseti R, Prasad V
Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against Covid-19.
N Engl J Med. 2023;389:284-285.
PubMed

MCCRINDLE BW, Manlhiot C
More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome. Reply.
N Engl J Med. 2023;389:287-288.
PubMed

XIA CY, Niu MM, Hu P
More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome.
N Engl J Med. 2023;389:287.
PubMed

PITTET LF, Messina NL, Curtis N
BCG to Protect against Covid-19 in Health Care Workers. Reply.
N Engl J Med. 2023;389:192.
PubMed

BENN CS, Netea MG, Aaby P
BCG to Protect against Covid-19 in Health Care Workers.
N Engl J Med. 2023;389:191-192.
PubMed

LOPEZ-CAMPOS GH, Valvano MA
BCG to Protect against Covid-19 in Health Care Workers.
N Engl J Med. 2023;389:191.
PubMed

June 2023

HALABI S, Wilder R, Gostin LO, Hurtado ML, et al
Sharing Pathogen Genomic Sequence Data - Toward Effective Pandemic Prevention, Preparedness, and Response.
N Engl J Med. 2023;388:2401-2404.
PubMed

CAO Z, Gao Y, Zhao R
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. Reply.
N Engl J Med. 2023;388:2396-2397.
PubMed

LI Y
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2396.
PubMed

EDWARDS JL
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2395-2396.
PubMed

BERGMANN F, Jorda A, Zeitlinger M
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2395.
PubMed

LIN DY, Fleming TR
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2395.
PubMed

MCGARRY BE, Gandhi AD, Barnett ML
Covid-19 Surveillance Testing in Nursing Homes. Reply.
N Engl J Med. 2023;388:2207-2208.
PubMed

STALL NM, Kain DC, Johnstone J
Covid-19 Surveillance Testing in Nursing Homes.
N Engl J Med. 2023;388:2207.
PubMed

DORFMAN D, Berger Z
Approving Workplace Accommodations for Patients with Long Covid - Advice for Clinicians.
N Engl J Med. 2023;388:2115-2117.
PubMed

NIKOLICH JZ, Rosen CJ
Toward Comprehensive Care for Long Covid.
N Engl J Med. 2023;388:2113-2115.
PubMed

GOSTIN LO, Gronvall GK
The Origins of Covid-19 - Why It Matters (and Why It Doesn't).
N Engl J Med. 2023 Jun 7. doi: 10.1056/NEJMp2305081.
PubMed

TSUBOI M, Herbst RS, John T, Kato T, et al
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
N Engl J Med. 2023 Jun 4. doi: 10.1056/NEJMoa2304594.
PubMed Abstract available

REIS G, Mills EJ, Glenn JS
Pegylated Interferon Lambda for Covid-19. Reply.
N Engl J Med. 2023;388:2108.
PubMed

WANG M, Tang L, Huang L
Pegylated Interferon Lambda for Covid-19.
N Engl J Med. 2023;388:2107-2108.
PubMed

ANDREAKOS E, Tsiodras S
Pegylated Interferon Lambda for Covid-19.
N Engl J Med. 2023;388:2107.
PubMed

May 2023

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: The Lasting Effects of Covid-19.
N Engl J Med. 2023;388:e76.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Ending the Covid-19 Emergency.
N Engl J Med. 2023;388:e72.
PubMed

LISCO A, Ortega-Villa AM, Mystakelis H, Anderson MV, et al
Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
N Engl J Med. 2023;388:1680-1691.
PubMed Abstract available

April 2023

PITTET LF, Messina NL, Orsini F, Moore CL, et al
Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
N Engl J Med. 2023;388:1582-1596.
PubMed Abstract available

KARRON RA
RSV Illness in the Young and the Old - The Beginning of the End?
N Engl J Med. 2023;388:1522-1524.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: When to Get a Second Covid-19 Booster Shot.
N Engl J Med. 2023;388:e64.
PubMed

ADAMS G, Moreno GK, Petros BA, Uddin R, et al
Viral Lineages in the 2022 RSV Surge in the United States.
N Engl J Med. 2023;388:1335-1337.
PubMed

KAMPMANN B, Madhi SA, Munjal I, Simoes EAF, et al
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2216480.
PubMed Abstract available

MULLER WJ, Madhi SA, Seoane Nunez B, Baca Cots M, et al
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMc2214773.
PubMed

WALSH EE, Perez Marc G, Zareba AM, Falsey AR, et al
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2213836.
PubMed Abstract available

March 2023

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Ending the Covid-19 Public Health Emergency.
N Engl J Med. 2023;388:e53.
PubMed

JABAGI MJ, Bertrand M, Botton J, Le Vu S, et al
Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
N Engl J Med. 2023 Mar 29. doi: 10.1056/NEJMc2302134.
PubMed

NEUZIL KM
An mRNA Influenza Vaccine - Could It Deliver?
N Engl J Med. 2023;388:1139-1141.
PubMed

MCGARRY BE, Gandhi AD, Barnett ML
Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes.
N Engl J Med. 2023;388:1101-1110.
PubMed Abstract available

MCCRINDLE BW, Harahsheh AS, Handoko R, Raghuveer G, et al
SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2023 Mar 22. doi: 10.1056/NEJMc2215074.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: The Future of Covid-19 Research.
N Engl J Med. 2023;388:e39.
PubMed

MANSOUR MK, King JD, Chen ST, Fishman JA, et al
Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.
N Engl J Med. 2023;388:926-937.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: The Path Forward for Covid-19 Therapeutics.
N Engl J Med. 2023;388:e36.
PubMed

OFFIT PA
Bivalent Covid-19 Vaccines. Reply.
N Engl J Med. 2023;388:10.
PubMed

MARKS PW, Califf RM
Bivalent Covid-19 Vaccines.
N Engl J Med. 2023;388:10.
PubMed

LI D, Duan M, Wang X, Gao P, et al
Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines.
N Engl J Med. 2023 Mar 1. doi: 10.1056/NEJMc2216233.
PubMed

February 2023

RUBIN EJ, Baden LR, Graham BS, Morrissey S, et al
Audio Interview: What to Expect from Covid-19 Vaccines.
N Engl J Med. 2023;388:e23.
PubMed

MUNOZ FM, Sher LD, Sabharwal C, Gurtman A, et al
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
N Engl J Med. 2023;388:621-634.
PubMed Abstract available

FALSEY AR, Williams K, Gymnopoulou E, Bart S, et al
Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults.
N Engl J Med. 2023;388:609-620.
PubMed Abstract available

PAPI A, Ison MG, Langley JM, Lee DG, et al
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.
N Engl J Med. 2023;388:595-608.
PubMed Abstract available

GRAHAM BS
The Journey to RSV Vaccines - Heralding an Era of Structure-Based Design.
N Engl J Med. 2023;388:579-581.
PubMed

CHEMAITELLY H, Tang P, Coyle P, Yassine HM, et al
Protection against Reinfection with the Omicron BA.2.75 Subvariant.
N Engl J Med. 2023;388:665-667.
PubMed

HUTH L, Schafer L, Almanzar G, Lupoli G, et al
Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis.
N Engl J Med. 2023 Feb 15. doi: 10.1056/NEJMc2216309.
PubMed

REIS G, Moreira Silva EAS, Medeiros Silva DC, Thabane L, et al
Early Treatment with Pegylated Interferon Lambda for Covid-19.
N Engl J Med. 2023;388:518-528.
PubMed Abstract available

WANG Q, Bowen A, Valdez R, Gherasim C, et al
Antibody Response to Omicron BA.4-BA.5 Bivalent Booster.
N Engl J Med. 2023;388:567-569.
PubMed

EL-SADR WM, Vasan A, El-Mohandes A
Facing the New Covid-19 Reality.
N Engl J Med. 2023;388:385-387.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Updating and Standardizing Covid-19 Vaccines.
N Engl J Med. 2023;388:e21.
PubMed

January 2023

Covid Vaccines - Playing the Long Game.
N Engl J Med. 2023;388:e5.
PubMed

ZOU J, Kurhade C, Patel S, Kitchin N, et al
Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine.
N Engl J Med. 2023 Jan 25. doi: 10.1056/NEJMc2214916.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Weighing the Protective Value of Covid-19 Infection.
N Engl J Med. 2023;388:e13.
PubMed

WINOKUR P, Gayed J, Fitz-Patrick D, Thomas SJ, et al
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med. 2023;388:214-227.
PubMed Abstract available

MILLER J, Hachmann NP, Collier AY, Lasrado N, et al
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1.
N Engl J Med. 2023 Jan 18. doi: 10.1056/NEJMc2214314.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 Vaccines and New Viral Variants.
N Engl J Med. 2023;388:e8.
PubMed

SCHUSTER JE, Hamdan L, Dulek DE, Kitko CL, et al
Influenza Vaccine in Pediatric Recipients of Hematopoietic-Cell Transplants.
N Engl J Med. 2023 Jan 11. doi: 10.1056/NEJMc2210825.
PubMed

OFFIT PA
Bivalent Covid-19 Vaccines - A Cautionary Tale.
N Engl J Med. 2023 Jan 11. doi: 10.1056/NEJMp2215780.
PubMed

COLLIER AY, Miller J, Hachmann NP, McMahan K, et al
Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.
N Engl J Med. 2023 Jan 11. doi: 10.1056/NEJMc2213948.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: The Expanding Arsenal of Oral Agents to Treat Covid-19.
N Engl J Med. 2023;388:e7.
PubMed

IMAI M, Ito M, Kiso M, Yamayoshi S, et al
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.
N Engl J Med. 2023;388:89-91.
PubMed

December 2022

ARBEL R, Wolff Sagy Y, Hammerman A
Nirmatrelvir Use during the Omicron Surge. Reply.
N Engl J Med. 2022;387:2480-2481.
PubMed

WEISS G
Nirmatrelvir Use during the Omicron Surge.
N Engl J Med. 2022;387:2480.
PubMed

NIELD B
Nirmatrelvir Use during the Omicron Surge.
N Engl J Med. 2022;387:2479-2480.
PubMed

SWETS MC, de Boer MGJ, Groeneveld GH
Nirmatrelvir Use during the Omicron Surge.
N Engl J Med. 2022;387:2479.
PubMed

CAO Z, Gao W, Bao H, Feng H, et al
VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2022 Dec 28. doi: 10.1056/NEJMoa2208822.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Potential Covid Vaccine Strategies.
N Engl J Med. 2022;387:e75.
PubMed

REIS G, Mills EJ
Ivermectin Treatment for Covid-19. Reply.
N Engl J Med. 2022;387:e66.
PubMed

BARUS R, Gautier S, Wabont G
Ivermectin Treatment for Covid-19.
N Engl J Med. 2022;387:e66.
PubMed

MEJIA JH, Jimenez CA
Ivermectin Treatment for Covid-19.
N Engl J Med. 2022;387:e66.
PubMed

FURLAN L
Ivermectin Treatment for Covid-19.
N Engl J Med. 2022;387:e66.
PubMed

BRAMANTE CT, Buse JB, Boulware DR
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply.
N Engl J Med. 2022;387:e65.
PubMed

SHUKLA AK, Misra S
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
N Engl J Med. 2022;387:e65.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Applying New Studies of Mpox and Ebola to Covid-19.
N Engl J Med. 2022;387:e74.
PubMed

GILBERT PB, Donis RO, Koup RA, Fong Y, et al
A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines.
N Engl J Med. 2022;387:2203-2206.
PubMed

RUBIN EJ, Baden LR, Hlatshwayo Davis M, Morrissey S, et al
Audio Interview: Covid-19 and Health Equity.
N Engl J Med. 2022;387:e73.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Five Disease Outbreaks beyond Covid-19.
N Engl J Med. 2022;387:e68.
PubMed

TAKASHITA E, Yamayoshi S, Halfmann P, Wilson N, et al
In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6.
N Engl J Med. 2022;387:2094-2097.
PubMed

November 2022

ABERG M, Smed-Sorensen A, Thalin C
Mucosal IgA against SARS-CoV-2 Omicron Infection. Reply.
N Engl J Med. 2022;387:e55.
PubMed

ZUO F, Marcotte H, Hammarstrom L, Pan-Hammarstrom Q, et al
Mucosal IgA against SARS-CoV-2 Omicron Infection.
N Engl J Med. 2022;387:e55.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Making Choices about Covid-19.
N Engl J Med. 2022;387:e64.
PubMed

RUBIN EJ, Baden LR, Marks P, Morrissey S, et al
Audio Interview: The FDA and Covid-19 Vaccines.
N Engl J Med. 2022;387:e60.
PubMed

GOLDEN MR, Wasserheit JN
Monkeypox - A Sobering Sentinel for Pandemic Preparedness and Sexual Health System Capacity.
N Engl J Med. 2022;387:1826-1829.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Masking and Covid-19.
N Engl J Med. 2022;387:e56.
PubMed

VENKATARAMANI V, Winkler F
Cognitive Deficits in Long Covid-19.
N Engl J Med. 2022;387:1813-1815.
PubMed

FRICCHIONE GL, Paul AB, Chemali Z, Kritzer MD, et al
Case 34-2022: A 57-Year-Old Woman with Covid-19 and Delusions.
N Engl J Med. 2022;387:1795-1803.
PubMed

RAIFMAN J, Green T
Universal Masking Policies in Schools and Mitigating the Inequitable Costs of Covid-19.
N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMe2213556.
PubMed

COWGER TL, Murray EJ, Clarke J, Bassett MT, et al
Lifting Universal Masking in Schools - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMoa2211029.
PubMed Abstract available

CANETTI M, Barda N, Gilboa M, Indenbaum V, et al
Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.
N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMc2211283.
PubMed

CHESKES S, Verbeek PR, Drennan IR, McLeod SL, et al
Defibrillation Strategies for Refractory Ventricular Fibrillation.
N Engl J Med. 2022 Nov 6. doi: 10.1056/NEJMoa2207304.
PubMed Abstract available

RUBIN EJ, Baden LR, Hardin CC, Morrissey S, et al
Audio Interview: Caring for Hospitalized Patients with Covid-19.
N Engl J Med. 2022;387:e51.
PubMed

CHEMAITELLY H, AlMukdad S, Ayoub HH, Altarawneh HN, et al
Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
N Engl J Med. 2022 Nov 2. doi: 10.1056/NEJMoa2210058.
PubMed Abstract available

October 2022

EMANUEL EJ, Upshur REG, Smith MJ
What Covid Has Taught the World about Ethics.
N Engl J Med. 2022;387:1542-1545.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection.
N Engl J Med. 2022;387:e50.
PubMed

CHIN ET, Leidner D, Lamson L, Lucas K, et al
Protection against Omicron from Vaccination and Previous Infection in a Prison System.
N Engl J Med. 2022 Oct 26. doi: 10.1056/NEJMoa2207082.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19: Where Are We Heading?
N Engl J Med. 2022;387:e47.
PubMed

ANDERSON EJ, Creech CB, Berthaud V, Piramzadian A, et al
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age.
N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMoa2209367.
PubMed Abstract available

WITBERG G, Magen O, Hoss S, Talmor-Barkan Y, et al
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.
N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMc2207270.
PubMed

HACHMANN NP, Miller J, Collier AY, Barouch DH, et al
Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6.
N Engl J Med. 2022 Oct 19. doi: 10.1056/NEJMc2212117.
PubMed

RUBIN EJ, Baden LR, Neuzil KM, Morrissey S, et al
Audio Interview: Developing New Covid-19 Vaccines.
N Engl J Med. 2022;387:e44.
PubMed

CHEMAITELLY H, Ayoub HH, Tang P, Hasan MR, et al
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2.
N Engl J Med. 2022 Oct 12. doi: 10.1056/NEJMc2211055.
PubMed

ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Hasan MR, et al
Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants.
N Engl J Med. 2022 Oct 5. doi: 10.1056/NEJMc2209306.
PubMed

September 2022

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Assessing Bivalent Vaccines against Covid-19.
N Engl J Med. 2022;387:e37.
PubMed

TAKASHITA E, Yamayoshi S, Fukushi S, Suzuki T, et al
Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75.
N Engl J Med. 2022;387:1236-1238.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Can Vaccines Prevent Transmission of Covid-19?
N Engl J Med. 2022;387:e30.
PubMed

THURNER L, Kessel C, Fadle N, Regitz E, et al
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.
N Engl J Med. 2022 Sep 21. doi: 10.1056/NEJMc2205667.
PubMed

CHALKIAS S, Harper C, Vrbicky K, Walsh SR, et al
A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
N Engl J Med. 2022 Sep 16. doi: 10.1056/NEJMoa2208343.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Developing Mucosal Immunity to Covid-19.
N Engl J Med. 2022;387:e29.
PubMed

HAVERVALL S, Marking U, Svensson J, Greilert-Norin N, et al
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.
N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2209651.
PubMed

COLLIE S, Nayager J, Bamford L, Bekker LG, et al
Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.
N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210093.
PubMed

SHEN X, Chalkias S, Feng J, Chen X, et al
Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.
N Engl J Med. 2022 Sep 9. doi: 10.1056/NEJMc2210648.
PubMed

SULLIVAN DJ, Gebo KA, Hanley DF
Convalescent Plasma for Covid-19. Reply.
N Engl J Med. 2022;387:955-956.
PubMed

PANETH N
Convalescent Plasma for Covid-19.
N Engl J Med. 2022;387:955.
PubMed

JOYNER MJ, Pirofski LA
Convalescent Plasma for Covid-19.
N Engl J Med. 2022;387:955.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Rolling Out New Covid-19 Vaccines.
N Engl J Med. 2022;387:e26.
PubMed

CHARNESS ME, Gupta K, Stack G, Strymish J, et al
Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment.
N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2206449.
PubMed

ANDERSON AS, Caubel P, Rusnak JM
Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2205944.
PubMed

LIN DY, Gu Y, Xu Y, Zeng D, et al
Effects of Vaccination and Previous Infection on Omicron Infections in Children.
N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2209371.
PubMed

QU P, Faraone JN, Evans JP, Zheng YM, et al
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.
N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2210546.
PubMed

DUPONT SC, Galea S
Science, Competing Values, and Trade-offs in Public Health - The Example of Covid-19 and Masking.
N Engl J Med. 2022 Sep 3. doi: 10.1056/NEJMp2207670.
PubMed

RUBIN EJ, Baden LR, Swaminathan S, Morrissey S, et al
Audio Interview: Covid-19 and the WHO.
N Engl J Med. 2022;387:e24.
PubMed

August 2022

BAROUCH DH
Covid-19 Vaccines - Immunity, Variants, Boosters.
N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMra2206573.
PubMed

MALATO J, Ribeiro RM, Leite PP, Casaca P, et al
Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants.
N Engl J Med. 2022 Aug 31. doi: 10.1056/NEJMc2209479.
PubMed

MACDONALD SM, Berv J
Losing Contact - Covid-19, Telemedicine, and the Patient-Provider Relationship.
N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMp2206471.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Choosing an Antiviral to Treat Covid-19.
N Engl J Med. 2022;387:e22.
PubMed

ARBEL R, Wolff Sagy Y, Hoshen M, Battat E, et al
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge.
N Engl J Med. 2022 Aug 24. doi: 10.1056/NEJMoa2204919.
PubMed Abstract available

ABDOOL KARIM SS, Devnarain N
Time to Stop Using Ineffective Covid-19 Drugs.
N Engl J Med. 2022;387:654-655.
PubMed

BRAMANTE CT, Huling JD, Tignanelli CJ, Buse JB, et al
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
N Engl J Med. 2022;387:599-610.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Combating Covid-19 Today and Tomorrow.
N Engl J Med. 2022;387:e17.
PubMed

JOST TS
Considering Race and Ethnicity in Covid Risk Assessments - Legal Concerns and Possible Solutions.
N Engl J Med. 2022;387:481-483.
PubMed

KOHANE I, Omenn GS
Understanding Covid Vaccine Efficacy over Time - Bridging a Gap Between Public Health and Health Care.
N Engl J Med. 2022 Aug 6. doi: 10.1056/NEJMp2201084.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox.
N Engl J Med. 2022;387:e16.
PubMed

TAKASHITA E, Yamayoshi S, Simon V, van Bakel H, et al
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants.
N Engl J Med. 2022;387:468-470.
PubMed

July 2022

RUBIN EJ, Baden LR, Currier JS, Morrissey S, et al
Audio Interview: Reinventing the Research Infrastructure to Address Covid-19.
N Engl J Med. 2022;387:e13.
PubMed

RUBIN EJ, Baden LR, Jha A, Morrissey S, et al
Audio Interview: A Look at the U.S. Government's Covid-19 Strategy.
N Engl J Med. 2022;387:e11.
PubMed

HAMMOND J, Bao W, Simon-Campos A
Nirmatrelvir for Nonhospitalized Adults with Covid-19. Reply.
N Engl J Med. 2022;387.
PubMed

MORRIS AM, Lee TC
Nirmatrelvir for Nonhospitalized Adults with Covid-19.
N Engl J Med. 2022;387.
PubMed

CHEN BS, Hung CH, Wei JC
Nirmatrelvir for Nonhospitalized Adults with Covid-19.
N Engl J Med. 2022;387.
PubMed

TAN SHX, Cook AR, Heng D, Ong B, et al
Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age.
N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMoa2203209.
PubMed Abstract available

MAIER HE, Balmaseda A, Saborio S, Ojeda S, et al
Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua.
N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMc2203985.
PubMed

RUBIN EJ, Baden LR, Marks P, Morrissey S, et al
Audio Interview: Covid-19 Vaccines and the FDA.
N Engl J Med. 2022;387:e10.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Designing the Next Covid-19 Vaccine.
N Engl J Med. 2022;387:e6.
PubMed

ZHAO X, Zhang R, Qiao S, Wang X, et al
Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines.
N Engl J Med. 2022 Jul 6. doi: 10.1056/NEJMc2206900.
PubMed

June 2022

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: How Effective is Covid-19 Vaccination in Children?
N Engl J Med. 2022;386:e78.
PubMed

WAXMAN JG, Magen O, Hernan MA
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine. Reply.
N Engl J Med. 2022;387.
PubMed

TUMMINIA A, Romano M
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2022;387.
PubMed

COHEN-STAVI CJ, Magen O, Barda N, Yaron S, et al
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.
N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMoa2205011.
PubMed Abstract available

BOUCAU J, Marino C, Regan J, Uddin R, et al
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.
N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2202092.
PubMed

LAUNAY O, Cachanado M, Luong Nguyen LB, Ninove L, et al
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.
N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2206711.
PubMed

SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
SARS-CoV-2 Infection in Patients with a History of VITT.
N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Vaccinating Young Children against Covid-19.
N Engl J Med. 2022;386:e77.
PubMed

GRIFFIN MR
A Challenge to Respiratory Syncytial Virus Illness in Adults.
N Engl J Med. 2022;386:2427-2428.
PubMed

SCHMOELE-THOMA B, Zareba AM, Jiang Q, Maddur MS, et al
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.
N Engl J Med. 2022;386:2377-2386.
PubMed Abstract available

HACHMANN NP, Miller J, Collier AY, Ventura JD, et al
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2206576.
PubMed

DESILVA M, Haapala J, Vazquez-Benitez G, Vesco KK, et al
Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2205276.
PubMed

HALASA NB, Olson SM, Staat MA, Newhams MM, et al
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMoa2204399.
PubMed Abstract available

RASMUSSEN SA, Jamieson DJ
Covid-19 Vaccination during Pregnancy - Two for the Price of One.
N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMe2206730.
PubMed

RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
Audio Interview: Viral Evolution and the Future of Monoclonal Antibodies.
N Engl J Med. 2022;386:e75.
PubMed

LEUCHTER RK, Jackson NJ, Mafi JN, Sarkisian CA, et al
Association between Covid-19 Vaccination and Influenza Vaccination Rates.
N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2204560.
PubMed

QU P, Faraone J, Evans JP, Zou X, et al
Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.
N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2206725.
PubMed

HOPKINS S, Hall V, Klenerman P
Protection against SARS-CoV-2 after Vaccination and Previous Infection. Reply.
N Engl J Med. 2022;386.
PubMed

MATUCHANSKY C
Protection against SARS-CoV-2 after Vaccination and Previous Infection.
N Engl J Med. 2022;386.
PubMed

ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Protecting the Immunocompromised from Covid-19.
N Engl J Med. 2022;386:e71.
PubMed

ABRAHAM J
Monoclonal Antibodies with Extended Half-Life to Prevent Covid-19.
N Engl J Med. 2022;386:2236-2238.
PubMed

JOLOBE OMP
Protection Due to Previous SARS-CoV-2 Infection.
N Engl J Med. 2022;386.
PubMed

SCHERER EM, Babiker A, Adelman MW, Allman B, et al
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.
N Engl J Med. 2022 Jun 8. doi: 10.1056/NEJMc2202861.
PubMed

RUBIN EJ, Baden LR, Moore PL, Morrissey S, et al
Audio Interview: Dissecting the Host Response to SARS-CoV-2.
N Engl J Med. 2022;386:e69.
PubMed

May 2022

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Waning Immunity against Covid-19.
N Engl J Med. 2022;386:e64.
PubMed

GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.
N Engl J Med. 2022 May 25. doi: 10.1056/NEJMoa2118946.
PubMed Abstract available

ACCORSI EK, Britton A, Shang N, Fleming-Dutra KE, et al
Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron.
N Engl J Med. 2022 May 25. doi: 10.1056/NEJMc2203165.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: What to Make of Covid-19 Hot Spots.
N Engl J Med. 2022;386:e63.
PubMed

BROWN PE, Fu SH, Bansal A, Newcombe L, et al
Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults.
N Engl J Med. 2022 May 18. doi: 10.1056/NEJMc2202879.
PubMed

EVANS JP, Qu P, Zeng C, Zheng YM, et al
Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants.
N Engl J Med. 2022 May 18. doi: 10.1056/NEJMc2205019.
PubMed

RUBIN EJ, Baden LR, Lipsitch M, Morrissey S, et al
Audio Interview: Forecasting the Future of Covid.
N Engl J Med. 2022;386:e58.
PubMed

CREECH CB, Anderson E, Berthaud V, Yildirim I, et al
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age.
N Engl J Med. 2022 May 11. doi: 10.1056/NEJMoa2203315.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Do We Need New Covid-19 Vaccines?
N Engl J Med. 2022;386:e52.
PubMed

ESTCOURT L, Callum J
Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.
N Engl J Med. 2022;386:1753-1754.
PubMed

HAGER KJ, Perez Marc G, Gobeil P, Diaz RS, et al
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2201300.
PubMed Abstract available

DAI L, Gao L, Tao L, Hadinegoro SR, et al
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2202261.
PubMed Abstract available

NOHYNEK H, Wilder-Smith A
Does the World Still Need New Covid-19 Vaccines?
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMe2204695.
PubMed

GRAY G, Collie S, Goga A, Garrett N, et al
Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
PubMed

PERSAD G, Pandya A
A Comprehensive Covid-19 Response - The Need for Economic Evaluation.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMp2202828.
PubMed

April 2022

RUBIN EJ, Baden LR, Marrazzo JM, Morrissey S, et al
Audio Interview: Communicating Covid-19 Science.
N Engl J Med. 2022;386:e53.
PubMed

SIMOES EAF, Center KJ, Tita ATN, Swanson KA, et al
Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.
N Engl J Med. 2022;386:1615-1626.
PubMed Abstract available

RUBIN EJ, Baden LR, Inglefinger JR, Morrissey S, et al
Audio Interview: The Effects of Covid-19 on Children.
N Engl J Med. 2022;386:e51.
PubMed

BHATTACHARYYA RP, Hanage WP
Intrinsic Severity of the SARS-CoV-2 Omicron Variant. Reply.
N Engl J Med. 2022 Apr 20. pii: 10.1056/NEJMc2203679.
PubMed

SHAFER SL
Intrinsic Severity of the SARS-CoV-2 Omicron Variant.
N Engl J Med. 2022 Apr 20. pii: 10.1056/NEJMc2203679.
PubMed

LEVIN MJ, Ustianowski A, De Wit S, Launay O, et al
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
N Engl J Med. 2022 Apr 20. doi: 10.1056/NEJMoa2116620.
PubMed Abstract available

OFFIT PA
Covid-19 Boosters - Where from Here?
N Engl J Med. 2022 Apr 13. doi: 10.1056/NEJMe2203329.
PubMed

MAGEN O, Waxman JG, Makov-Assif M, Vered R, et al
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
N Engl J Med. 2022 Apr 13. doi: 10.1056/NEJMoa2201688.
PubMed Abstract available

DRAIN PK
Rapid Diagnostic Testing for SARS-CoV-2. Reply.
N Engl J Med. 2022;386.
PubMed

BOGATY P
Rapid Diagnostic Testing for SARS-CoV-2.
N Engl J Med. 2022;386.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Do We Need a Fourth Dose of Covid Vaccine?
N Engl J Med. 2022;386:e45.
PubMed

MOORE PL, Baden LR
Omicron - Decoupling Infection from Severe Disease.
N Engl J Med. 2022;386:1361-1362.
PubMed

HORWITZ JR, Wiley LF
Not Ready for the End Game - Why Ending Federal Covid-19 Emergency Declarations Will Harm Access to Care.
N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMp2203468.
PubMed

YOON SK, Hegmann KT, Thiese MS, Burgess JL, et al
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.
N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMc2201821.
PubMed

LEE KC, Morgan AU, Chaiyachati KH, Asch DA, et al
Pulse Oximetry for Monitoring Patients with Covid-19 at Home - A Pragmatic, Randomized Trial.
N Engl J Med. 2022 Apr 6. doi: 10.1056/NEJMc2201541.
PubMed

BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.
N Engl J Med. 2022 Apr 5. doi: 10.1056/NEJMoa2201570.
PubMed Abstract available

March 2022

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Effectiveness of Covid-19 Vaccination in Children.
N Engl J Med. 2022;386:e39.
PubMed

KLEIN NP
Added Benefit of Covid-19 Vaccination after Previous Infection.
N Engl J Med. 2022;386:1278-1279.
PubMed

REIS G, Silva EASM, Silva DCM, Thabane L, et al
Effect of Early Treatment with Ivermectin among Patients with Covid-19.
N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2115869.
PubMed Abstract available

SULLIVAN DJ, Gebo KA, Shoham S, Bloch EM, et al
Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2119657.
PubMed Abstract available

PRICE AM, Olson SM, Newhams MM, Halasa NB, et al
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2202826.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19: Why We Publish What We Do.
N Engl J Med. 2022;386:e38.
PubMed

VYAS JM, Castle AC, Bourgouin PP, Turbett SE, et al
Case 9-2022: A 56-Year-Old Woman with Fever, Myalgias, Diarrhea, and Cough.
N Engl J Med. 2022;386:1166-1174.
PubMed

ROSSLER A, Knabl L, von Laer D, Kimpel J, et al
Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection.
N Engl J Med. 2022 Mar 23. doi: 10.1056/NEJMc2201607.
PubMed

MOREIRA ED JR, Kitchin N, Xu X, Dychter SS, et al
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
N Engl J Med. 2022 Mar 23. doi: 10.1056/NEJMoa2200674.
PubMed Abstract available

QI X, Qiu H, Hao S, Zhu F, et al
Human Infection with an Avian-Origin Influenza A (H10N3) Virus.
N Engl J Med. 2022;386:1087-1088.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Can We Make More Effective Covid-19 Vaccines?
N Engl J Med. 2022;386:e36.
PubMed

DE ANDA C, Johnson MG, Pedley A
Molnupiravir for Covid-19 in Nonhospitalized Patients. Reply.
N Engl J Med. 2022;386.
PubMed

ROBERFROID D, Jespers V, Hulstaert F
Molnupiravir for Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2022;386.
PubMed

LEVENSTEIN S
Molnupiravir for Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2022;386.
PubMed

SELVI-SABATER P, Abellon-Ruiz J
Molnupiravir for Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2022;386.
PubMed

THORLUND K, Sheldrick K, Mills E
Molnupiravir for Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2022;386.
PubMed

REGEV-YOCHAY G, Gonen T, Gilboa M, Mandelboim M, et al
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
N Engl J Med. 2022 Mar 16. doi: 10.1056/NEJMc2202542.
PubMed

SHAPIRO AE, Gupta A
Early Treatment with Sotrovimab for Covid-19. Reply.
N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
PubMed

FUJIWARA Y
Early Treatment with Sotrovimab for Covid-19.
N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
PubMed

ORIGUEN J, Caro-Teller JM, Lopez-Medrano F
Early Treatment with Sotrovimab for Covid-19.
N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
PubMed

HATZL S, Krause R, Schilcher G
Early Treatment with Sotrovimab for Covid-19.
N Engl J Med. 2022 Mar 16. pii: 10.1056/NEJMc2201606.
PubMed

YU J, Collier AY, Rowe M, Mardas F, et al
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
N Engl J Med. 2022 Mar 16. doi: 10.1056/NEJMc2201849.
PubMed

RUBIN EJ, Baden LR, Hunter D, Morrissey S, et al
Audio Interview: Making Covid-19 Vaccines Available around the World.
N Engl J Med. 2022;386:e31.
PubMed

TAKASHITA E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, et al
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMc2201933.
PubMed

ROCKETT R, Basile K, Maddocks S, Fong W, et al
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use.
N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMc2120219.
PubMed

ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, AlMukdad S, et al
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMoa2200797.
PubMed Abstract available

MONTO AS
The Future of SARS-CoV-2 Vaccination. Reply.
N Engl J Med. 2022;386:899-900.
PubMed

BACHMANN MF, Mohsen MO, Speiser DE
The Future of SARS-CoV-2 Vaccination.
N Engl J Med. 2022;386:899.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Using Our Covid-19 Experience to Develop Vaccines More Quickly.
N Engl J Med. 2022;386:e29.
PubMed

DOMACHOWSKE J, Madhi SA, Simoes EAF, Atanasova V, et al
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
N Engl J Med. 2022;386:892-894.
PubMed

GEE JE, Bower WA, Kunkel A, Petras J, et al
Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray.
N Engl J Med. 2022;386:861-868.
PubMed Abstract available

HAMMITT LL, Dagan R, Yuan Y, Baca Cots M, et al
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.
N Engl J Med. 2022;386:837-846.
PubMed Abstract available

MELLO MM, Parmet WE
U.S. Public Health Law - Foundations and Emerging Shifts.
N Engl J Med. 2022;386:805-808.
PubMed

WALTER EB, Talaat KR, Gurtman A
More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
N Engl J Med. 2022;386.
PubMed

LEIBOWITZ R, Schurr E, Hirsch O
More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med. 2022;386.
PubMed

TAYTARD J, Prevost B, Corvol H
More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med. 2022;386.
PubMed

ANDREWS N, Stowe J, Kirsebom F, Toffa S, et al
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
N Engl J Med. 2022 Mar 2. doi: 10.1056/NEJMoa2119451.
PubMed Abstract available

SAVILLE M, Cramer JP, Downham M, Hacker A, et al
Delivering Pandemic Vaccines in 100 Days - What Will It Take?
N Engl J Med. 2022 Mar 2. doi: 10.1056/NEJMp2202669.
PubMed

February 2022

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Understanding the Omicron Variant of SARS-CoV-2.
N Engl J Med. 2022;386:e27.
PubMed

HUNTER DJ, Abdool Karim SS, Baden LR, Farrar JJ, et al
Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good.
N Engl J Med. 2022 Feb 23. doi: 10.1056/NEJMe2202547.
PubMed

MADHI SA, Kwatra G, Myers JE, Jassat W, et al
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.
N Engl J Med. 2022 Feb 23. doi: 10.1056/NEJMoa2119658.
PubMed Abstract available

ANDERSON LJ, Walsh EE
The Challenge of Respiratory Syncytial Virus Human Challenge Studies.
N Engl J Med. 2022;386:696-697.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New Antiviral against Covid-19.
N Engl J Med. 2022;386:e25.
PubMed

AHMAD A, Eze K, Noulin N, Horvathova V, et al
EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge.
N Engl J Med. 2022;386:655-666.
PubMed Abstract available

FLEISHER LA, Schreiber M, Cardo D, Srinivasan A, et al
Health Care Safety during the Pandemic and Beyond - Building a System That Ensures Resilience.
N Engl J Med. 2022;386:609-611.
PubMed

GOTTLIEB RL, Juneja K, Hill JA
Outpatient Remdesivir to Prevent Progression to Severe Covid-19. Reply.
N Engl J Med. 2022 Feb 16. pii: 10.1056/NEJMc2200591.
PubMed

ENNEZAT PV
Outpatient Remdesivir to Prevent Progression to Severe Covid-19.
N Engl J Med. 2022 Feb 16. pii: 10.1056/NEJMc2200591.
PubMed

HAMMERMAN A, Sergienko R, Friger M, Beckenstein T, et al
Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19.
N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2119497.
PubMed Abstract available

HALL V, Foulkes S, Insalata F, Kirwan P, et al
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2118691.
PubMed Abstract available

HAMMOND J, Leister-Tebbe H, Gardner A, Abreu P, et al
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.
N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2118542.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 as an Endemic Disease.
N Engl J Med. 2022;386:e21.
PubMed

ARBEL R, Sergienko R, Hammerman A
BNT162b2 Vaccine Booster and Covid-19 Mortality. Reply.
N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
PubMed

SADOFF J, Gray G, Vandebosch A, Cardenas V, et al
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMoa2117608.
PubMed Abstract available

PILZ S
BNT162b2 Vaccine Booster and Covid-19 Mortality.
N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
PubMed

ROHBAN T
BNT162b2 Vaccine Booster and Covid-19 Mortality.
N Engl J Med. 2022 Feb 9. pii: 10.1056/NEJMc2120044.
PubMed

ALTARAWNEH HN, Chemaitelly H, Hasan MR, Ayoub HH, et al
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.
N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMc2200133.
PubMed

MAYR FB, Talisa VB, Shaikh O, Yende S, et al
Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans.
N Engl J Med. 2022 Feb 9. doi: 10.1056/NEJMc2200415.
PubMed

RUBIN EJ, Baden LR, Rosen CJ, Morrissey S, et al
Audio Interview: Studying Long Covid.
N Engl J Med. 2022;386:e20.
PubMed

BRAGA NETO MB, Badley AD, Parikh SA, Graham RP, et al
Calm before the Storm.
N Engl J Med. 2022;386:479-485.
PubMed

MURPHY WJ, Longo DL
Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination. Reply.
N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
PubMed

HARVILLE TO, Arthur JM
Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
PubMed

DE MARIA A
Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
N Engl J Med. 2022 Feb 2. pii: 10.1056/NEJMc2119443.
PubMed

BHATTACHARYYA RP, Hanage WP
Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant.
N Engl J Med. 2022 Feb 2. doi: 10.1056/NEJMp2119682.
PubMed

January 2022

RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
Audio Interview: Addressing the Omicron Variant of SARS-CoV-2.
N Engl J Med. 2022;386:e16.
PubMed

TAKASHITA E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, et al
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2119407.
PubMed

ABU-RADDAD LJ, Chemaitelly H, Bertollini R
Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.
N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2119432.
PubMed

ROACH A, Chikwe J, Catarino P, Rampolla R, et al
Lung Transplantation for Covid-19-Related Respiratory Failure in the United States.
N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMc2117024.
PubMed

RUBIN EJ, Baden LR, Fineberg HV, Morrissey S, et al
Audio Interview: Crushing the Covid-19 Curve.
N Engl J Med. 2022;386:e13.
PubMed

WALTER EB, Talaat KR, Gurtman A
BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
N Engl J Med. 2022;386.
PubMed

MINTZKER Y
BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med. 2022;386.
PubMed

FANG SF, Liu N, Du HW
BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
N Engl J Med. 2022;386.
PubMed

ABU-RADDAD LJ, Chemaitelly H, Bertollini R
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.
N Engl J Med. 2022 Jan 19. doi: 10.1056/NEJMc2117933.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 Takeaways at Podcast 100.
N Engl J Med. 2022;386:e11.
PubMed

WEINSTEIN DF
Reengineering GME in a Pandemic - Looking Back, and Forward.
N Engl J Med. 2022;386:97.
PubMed

ANDREWS N, Tessier E, Stowe J, Gower C, et al
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.
N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2115481.
PubMed Abstract available

EDWARDS KM
Sparing of Severe Covid-19 in Vaccinated Adolescents.
N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMe2118471.
PubMed

ROSSLER A, Riepler L, Bante D, von Laer D, et al
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.
N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMc2119236.
PubMed

OLSON SM, Newhams MM, Halasa NB, Price AM, et al
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2117995.
PubMed Abstract available

LIN DY, Gu Y, Wheeler B, Young H, et al
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina.
N Engl J Med. 2022 Jan 12. doi: 10.1056/NEJMoa2117128.
PubMed Abstract available

DRAIN PK
Rapid Diagnostic Testing for SARS-CoV-2.
N Engl J Med. 2022 Jan 7. doi: 10.1056/NEJMcp2117115.
PubMed

RUBIN EJ, Baden LR, Drosten C, Morrissey S, et al
Audio Interview: Covid-19 - The Outlook in Europe.
N Engl J Med. 2022;386:e9.
PubMed

GONEN T, Lustig Y, Regev-Yochay G
Covid-19 Infections in Vaccinated Health Care Workers. Reply.
N Engl J Med. 2022;386.
PubMed

RASTMANESH R
Covid-19 Infections in Vaccinated Health Care Workers.
N Engl J Med. 2022;386.
PubMed

EYRE DW, Taylor D, Purver M, Chapman D, et al
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.
N Engl J Med. 2022 Jan 5. doi: 10.1056/NEJMoa2116597.
PubMed Abstract available

PAI M, Kasaeva T, Swaminathan S
Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery.
N Engl J Med. 2022 Jan 5. doi: 10.1056/NEJMp2118145.
PubMed

December 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 Vaccination and the Omicron Variant.
N Engl J Med. 2021;385:e102.
PubMed

RITTENBERG E
Trust, Faith, and Covid.
N Engl J Med. 2021;385:2504-2505.
PubMed

SCHMIDT F, Muecksch F, Weisblum Y, Da Silva J, et al
Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
N Engl J Med. 2021 Dec 30. doi: 10.1056/NEJMc2119641.
PubMed

MCGREW S, Taylor HA
Adolescents, Parents, and Covid-19 Vaccination - Who Should Decide?
N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMp2116771.
PubMed

NEMET I, Kliker L, Lustig Y, Zuckerman N, et al
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119358.
PubMed

KISSLER SM, Fauver JR, Mack C, Tai CG, et al
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.
N Engl J Med. 2021;385:2489-2491.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A Potential New Agent to Treat Covid-19.
N Engl J Med. 2021;385:e101.
PubMed

GENG LN, Verghese A, Tilburt JC
Consultative Medicine - An Emerging Specialty for Patients with Perplexing Conditions.
N Engl J Med. 2021;385:2478-2484.
PubMed

FOXWORTH R, Redvers N, Moreno MA, Lopez-Carmen VA, et al
Covid-19 Vaccination in American Indians and Alaska Natives - Lessons from Effective Community Responses.
N Engl J Med. 2021;385:2403-2406.
PubMed

GOTTLIEB RL, Vaca CE, Paredes R, Mera J, et al
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMoa2116846.
PubMed Abstract available

MUHSEN K, Maimon N, Mizrahi A, Varticovschi B, et al
Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel.
N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2117385.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
N Engl J Med. 2021;385:e100.
PubMed

WHITLEY R
Molnupiravir - A Step toward Orally Bioavailable Therapies for Covid-19.
N Engl J Med. 2021 Dec 16. doi: 10.1056/NEJMe2117814.
PubMed

JAYK BERNAL A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, et al
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2021 Dec 16. doi: 10.1056/NEJMoa2116044.
PubMed Abstract available

CHEMAITELLY H, Bertollini R, Abu-Raddad LJ
Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant.
N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMc2110300.
PubMed

HORTON LE, Abeles SR, Torriani FJ
SARS-CoV-2 Infection in Vaccinated Health Care Workers. Reply.
N Engl J Med. 2021 Dec 15. pii: 10.1056/NEJMc2117119.
PubMed

LILLERI D, Marena C, Baldanti F
SARS-CoV-2 Infection in Vaccinated Health Care Workers.
N Engl J Med. 2021 Dec 15. pii: 10.1056/NEJMc2117119.
PubMed

MORENS DM, Taubenberger JK, Fauci AS
Universal Coronavirus Vaccines - An Urgent Need.
N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMp2118468.
PubMed

DUNKLE LM, Kotloff KL, Gay CL, Anez G, et al
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
N Engl J Med. 2021 Dec 15. doi: 10.1056/NEJMoa2116185.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Waning Immunity against SARS-CoV-2.
N Engl J Med. 2021;385:e99.
PubMed

KNUDSEN J, Chokshi DA
Covid-19 and the Safety Net - Moving from Straining to Sustaining.
N Engl J Med. 2021;385:2209-2211.
PubMed

ARBEL R, Hammerman A, Sergienko R, Friger M, et al
BNT162b2 Vaccine Booster and Mortality Due to Covid-19.
N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMoa2115624.
PubMed Abstract available

BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
Protection against Covid-19 by BNT162b2 Booster across Age Groups.
N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMoa2115926.
PubMed Abstract available

WALKER AS, Vihta KD, Gethings O, Pritchard E, et al
Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom.
N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMc2103227.
PubMed

MCGARRY BE, Barnett ML, Grabowski DC, Gandhi AD, et al
Nursing Home Staff Vaccination and Covid-19 Outcomes.
N Engl J Med. 2021 Dec 8. doi: 10.1056/NEJMc2115674.
PubMed

RUBIN EJ, Baden LR, Abdool Karim SS, Morrissey S, et al
Audio Interview: The Omicron Variant of SARS-CoV-2.
N Engl J Med. 2021;385:e96.
PubMed

CAFORIO ALP
Receipt of mRNA Vaccine against Covid-19 and Myocarditis.
N Engl J Med. 2021;385:2189-2190.
PubMed

RUBIN EJ, Longo DL
Covid-19 mRNA Vaccines - Six of One, Half a Dozen of the Other.
N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMe2117446.
PubMed

ROSENBERG ES, Dorabawila V, Easton D, Bauer UE, et al
Covid-19 Vaccine Effectiveness in New York State.
N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMoa2116063.
PubMed Abstract available

DICKERMAN BA, Gerlovin H, Madenci AL, Kurgansky KE, et al
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans.
N Engl J Med. 2021 Dec 1. doi: 10.1056/NEJMoa2115463.
PubMed Abstract available

November 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: What's Gone Right in Our Battle against Covid-19.
N Engl J Med. 2021;385:e95.
PubMed

ABU-RADDAD LJ, Chemaitelly H, Bertollini R
Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections.
N Engl J Med. 2021 Nov 24. doi: 10.1056/NEJMc2108120.
PubMed

MURPHY WJ, Longo DL
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
N Engl J Med. 2021 Nov 24. doi: 10.1056/NEJMcibr2113694.
PubMed

ZARYCHANSKI R, Lawler PR, Goligher E
Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
N Engl J Med. 2021;385:2014.
PubMed

FERNANDES TM, McGuire WC, Morris TA
Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
N Engl J Med. 2021;385:2013.
PubMed

STERPETTI AV
Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
N Engl J Med. 2021;385:2013-2014.
PubMed

RUBIN EJ, Baden LR, Mello MM, Morrissey S, et al
Audio Interview: The Legal Basis for Covid-19 Restrictions and Mandates.
N Engl J Med. 2021;385:e88.
PubMed

RUBIN EJ, Baden LR, Grinsztejn B, Morrissey S, et al
Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children.
N Engl J Med. 2021;385:e79.
PubMed

LOPEZ BERNAL J, Gower C, Andrews N
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply.
N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
PubMed

EMANI VR, Reddy R, Goswami S
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
PubMed

LINSENMEYER K, Gupta K, Charness ME
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
PubMed

TORGOVNICK J
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
PubMed

MONTO AS
The Future of SARS-CoV-2 Vaccination - Lessons from Influenza.
N Engl J Med. 2021 Nov 6. doi: 10.1056/NEJMp2113403.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
N Engl J Med. 2021;385:e78.
PubMed

SCULLY M
VITT after ChAdOx1 nCoV-19 Vaccination. Reply.
N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
PubMed

GREINACHER A, Schonborn L, Thiele T
VITT after ChAdOx1 nCoV-19 Vaccination. Reply.
N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
PubMed

WEBER C, von Hundelshausen P, Siess W
VITT after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
PubMed

SANTIN AD
VITT after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
PubMed

URIU K, Kimura I, Shirakawa K, Takaori-Kondo A, et al
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum.
N Engl J Med. 2021 Nov 3. doi: 10.1056/NEJMc2114706.
PubMed

October 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children.
N Engl J Med. 2021;385:e74.
PubMed

CHIN MH
Uncomfortable Truths - What Covid-19 Has Revealed about Chronic-Disease Care in America.
N Engl J Med. 2021;385:1633-1636.
PubMed

ASKENASE PW
Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
N Engl J Med. 2021;385:1720-1721.
PubMed

GUPTA A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, et al
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMoa2107934.
PubMed Abstract available

GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
Waning Immunity after the BNT162b2 Vaccine in Israel.
N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMoa2114228.
PubMed Abstract available

DAGAN N, Barda N, Balicer RD
Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex.
N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMc2115045.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New Look at Covid-19 Vaccine Boosters.
N Engl J Med. 2021;385:e72.
PubMed

MALLETT SD
Peak Moments - When Kindergarten Is High Risk.
N Engl J Med. 2021;385:1543-1545.
PubMed

MAGNUS MC, Gjessing HK, Eide HN, Wilcox AJ, et al
Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage.
N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114466.
PubMed

TEMPLE C, Hoang R, Hendrickson RG
Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19.
N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114907.
PubMed

CHIN ET, Leidner D, Zhang Y, Long E, et al
Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison.
N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114089.
PubMed

SHEIKH A, Robertson C, Taylor B
BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.
N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2113864.
PubMed

REIS BY, Barda N, Leshchinsky M, Kepten E, et al
Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.
N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114290.
PubMed

NOLAN T, Fortanier AC, Leav B, Poder A, et al
Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
N Engl J Med. 2021;385:1485-1495.
PubMed Abstract available

RUBIN EJ, Baden LR, Wu KJ, Morrissey S, et al
Audio Interview: Reporting on Covid-19.
N Engl J Med. 2021;385:e66.
PubMed

HOCK H, Kelly HR, Meyerowitz EA, Frigault MJ, et al
Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae.
N Engl J Med. 2021;385:1511-1520.
PubMed

BALSARI S, Kiang MV, Buckee CO
Data in Crisis - Rethinking Disaster Preparedness in the United States.
N Engl J Med. 2021;385:1526-1530.
PubMed

WHITE EM, Mor V
SARS-CoV-2 Infection among Nursing Home Residents. Reply.
N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114113.
PubMed

CHANDRASEKAR B
SARS-CoV-2 Infection among Nursing Home Residents.
N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114113.
PubMed

KORLEY FK, Durkalski-Mauldin V, Callaway CW
Convalescent Plasma for Outpatients with Covid-19. Reply.
N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
PubMed

SCHULZ E
Convalescent Plasma for Outpatients with Covid-19.
N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
PubMed

FISHER D, Malnick S
Convalescent Plasma for Outpatients with Covid-19.
N Engl J Med. 2021 Oct 13. pii: 10.1056/NEJMc2114591.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Are Covid-19 Vaccine Boosters Necessary?
N Engl J Med. 2021;385:e63.
PubMed

THOMPSON MG, Grant L, Meece J
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. Reply.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
PubMed

ZHANG C, Yin G
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
PubMed

SCHOOLEY RT
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
PubMed

SANTACATTERINA M, Sanders JW, Weintraub WS
Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
PubMed

O'BRIEN MP, Hou P, Weinreich DM
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. Reply.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113862.
PubMed

MERISON T, Goldman A, Bomze D
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113862.
PubMed

WITBERG G, Barda N, Hoss S, Richter I, et al
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.
N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2110737.
PubMed Abstract available

MEVORACH D, Anis E, Cedar N, Bromberg M, et al
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2109730.
PubMed Abstract available

CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
PubMed Abstract available

LEVIN EG, Lustig Y, Cohen C, Fluss R, et al
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114583.
PubMed Abstract available

September 2021

RUBIN EJ, Baden LR, Tofel R, Morrissey S, et al
Audio Interview: Covid-19 and the Media.
N Engl J Med. 2021;385:e59.
PubMed

RAPEPORT G, Chiu C, McShane H
SARS-CoV-2 Human Challenge Studies. Reply.
N Engl J Med. 2021 Sep 29. pii: 10.1056/NEJMc2113574.
PubMed

STEUWER B, Eyal N
SARS-CoV-2 Human Challenge Studies.
N Engl J Med. 2021 Sep 29. pii: 10.1056/NEJMc2113574.
PubMed

WEINREICH DM, Sivapalasingam S, Norton T, Ali S, et al
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
N Engl J Med. 2021 Sep 29. doi: 10.1056/NEJMoa2108163.
PubMed Abstract available

FALSEY AR, Sobieszczyk ME, Hirsch I, Sproule S, et al
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
N Engl J Med. 2021 Sep 29. doi: 10.1056/NEJMoa2105290.
PubMed Abstract available

AMIT S, Gonen T, Regev-Yochay G
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. Reply.
N Engl J Med. 2021;385.
PubMed

JUNG J, Sung H, Kim SH
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
N Engl J Med. 2021;385.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Vaccine Efficacy and Boosters in Covid-19.
N Engl J Med. 2021;385:e54.
PubMed

ESSEX R, Weldon SM
Health Care Worker Strikes and the Covid Pandemic. Reply.
N Engl J Med. 2021;385:e43.
PubMed

CHAN SSC
Health Care Worker Strikes and the Covid Pandemic.
N Engl J Med. 2021;385:e43.
PubMed

SON MBF, Newburger JW, Randolph AG
Therapy for Multisystem Inflammatory Syndrome in Children. Reply.
N Engl J Med. 2021;385:e42.
PubMed

MCARDLE AJ, Cunnington AJ, Levin M
Therapy for Multisystem Inflammatory Syndrome in Children. Reply.
N Engl J Med. 2021;385:e42.
PubMed

OULDALI N, Belot A, Angoulvant F
Therapy for Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2021;385:e42.
PubMed

HARLEY JB
Therapy for Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2021;385:e42.
PubMed

JONES DS, Podolsky SH
Mask Wars.
N Engl J Med. 2021;385:1159-1161.
PubMed

EL SAHLY HM, Baden LR, Essink B, Doblecki-Lewis S, et al
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2113017.
PubMed Abstract available

PILISHVILI T, Gierke R, Fleming-Dutra KE, Farrar JL, et al
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.
N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2106599.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
N Engl J Med. 2021;385:e48.
PubMed

NORTH CS, Sorg EM, Youn S, Chu JT, et al
Case 28-2021: A 37-Year-Old Woman with Covid-19 and Suicidal Ideation.
N Engl J Med. 2021;385:1125-1132.
PubMed

FRENCK RW JR, Dormitzer PR, Gurtman A
BNT162b2 Covid-19 Vaccine in Adolescents. Reply.
N Engl J Med. 2021;385.
PubMed

LIN CH
BNT162b2 Covid-19 Vaccine in Adolescents.
N Engl J Med. 2021;385.
PubMed

JARA A, Undurraga EA, Araos R
Effectiveness of an Inactivated SARS-CoV-2 Vaccine. Reply.
N Engl J Med. 2021;385.
PubMed

ONISHI FJ, Goto JM
Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
N Engl J Med. 2021;385.
PubMed

CHI H, Chiu NC, Lin CY
Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
N Engl J Med. 2021;385.
PubMed

OKHOTIN A
Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
N Engl J Med. 2021;385.
PubMed

BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.
N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2114255.
PubMed Abstract available

FALSEY AR, Frenck RW Jr, Walsh EE, Kitchin N, et al
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMc2113468.
PubMed

THOMAS SJ, Moreira ED Jr, Kitchin N, Absalon J, et al
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2110345.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Protecting against Severe Disease and Transmission.
N Engl J Med. 2021;385:e44.
PubMed

MEANEY-DELMAN DM, Ellington SR, Shimabukuro TT
On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Reply.
N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
PubMed

SUN H
On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
PubMed

DEAN NE, Hogan JW, Schnitzer ME
Covid-19 Vaccine Effectiveness and the Test-Negative Design.
N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMe2113151.
PubMed

THOMPSON MG, Stenehjem E, Grannis S, Ball SW, et al
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMoa2110362.
PubMed Abstract available

SHAH ASV, Gribben C, Bishop J, Hanlon P, et al
Effect of Vaccination on Transmission of SARS-CoV-2.
N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMc2106757.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New Round of Rising Covid-19 Numbers.
N Engl J Med. 2021;385:e41.
PubMed

WILDER-SMITH A, Mulholland K
Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
N Engl J Med. 2021;385:946-948.
PubMed

WERNER RM, Glied SA
Covid-Induced Changes in Health Care Delivery - Can They Last?
N Engl J Med. 2021;385:868-870.
PubMed

KEEHNER J, Horton LE, Binkin NJ, Laurent LC, et al
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce.
N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMc2112981.
PubMed

MELLO MM, Parmet WE
Public Health Law after Covid-19.
N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMp2112193.
PubMed

August 2021

LEVY JH, Connors JM
Heparin Resistance - Clinical Perspectives and Management Strategies.
N Engl J Med. 2021;385:826-832.
PubMed

PAPINENI P
A Pink Salwar.
N Engl J Med. 2021;385:774-775.
PubMed

LEE GM
The Importance of Context in Covid-19 Vaccine Safety.
N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMe2112543.
PubMed

BARDA N, Dagan N, Ben-Shlomo Y, Kepten E, et al
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMoa2110475.
PubMed Abstract available

UZUN G, Althaus K, Bakchoul T
No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMc2111305.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Aspects of Covid-19 Immunity.
N Engl J Med. 2021;385:e31.
PubMed

ROSAS IO, Raby B, Tsai L
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
PubMed

GORDON AC, Angus DC, Derde LPG
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
PubMed

BROWN MJ, Alazawi W, Kanoni S
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
PubMed

TAN CW, Chia WN, Young BE, Zhu F, et al
Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors.
N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMoa2108453.
PubMed Abstract available

KORLEY FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, et al
Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMoa2103784.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Monoclonal Antibodies and Booster Shots.
N Engl J Med. 2021;385:e29.
PubMed

BARAS SHREIBATI J
When Low Tech Wins.
N Engl J Med. 2021;385:581-583.
PubMed

PHILLIPS S, Williams MA
Confronting Our Next National Health Disaster - Long-Haul Covid.
N Engl J Med. 2021;385:577-579.
PubMed

WILLIAMS WW, Ingelfinger JR
Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients.
N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMe2112866.
PubMed

PAVORD S, Scully M, Hunt BJ, Lester W, et al
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
PubMed Abstract available

ALI K, Berman G, Zhou H, Deng W, et al
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.
N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109522.
PubMed Abstract available

HALL VG, Ferreira VH, Ku T, Ierullo M, et al
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMc2111462.
PubMed

COREY L, Beyrer C, Cohen MS, Michael NL, et al
SARS-CoV-2 Variants in Patients with Immunosuppression.
N Engl J Med. 2021;385:562-566.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Looking Back and Looking Forward - Part 2.
N Engl J Med. 2021;385:e25.
PubMed

GOLIGHER EC, Bradbury CA, McVerry BJ, Lawler PR, et al
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2103417.
PubMed Abstract available

LAWLER PR, Goligher EC, Berger JS, Neal MD, et al
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2105911.
PubMed Abstract available

TEN CATE H
Surviving Covid-19 with Heparin?
N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMe2111151.
PubMed

O'BRIEN MP, Forleo-Neto E, Musser BJ, Isa F, et al
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med. 2021 Aug 4. doi: 10.1056/NEJMoa2109682.
PubMed Abstract available

July 2021

GUIMARAES PO, Quirk D, Furtado RH, Maia LN, et al
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med. 2021;385:406-415.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Looking Back and Looking Forward - Part 1.
N Engl J Med. 2021;385:e24.
PubMed

BERGWERK M, Gonen T, Lustig Y, Amit S, et al
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
N Engl J Med. 2021 Jul 28. doi: 10.1056/NEJMoa2109072.
PubMed Abstract available

RUBIN EJ, Baden LR, Armstrong KA, Morrissey S, et al
Audio Interview: The Impact of Covid-19 on Trainees and Junior Faculty.
N Engl J Med. 2021;385:e21.
PubMed

MADHI SA, Izu A, Pollard AJ
ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.
N Engl J Med. 2021;385.
PubMed

STRUYF F, Sadoff J, Douoguih M
ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
N Engl J Med. 2021;385.
PubMed

LOPEZ BERNAL J, Andrews N, Gower C, Gallagher E, et al
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMoa2108891.
PubMed Abstract available

RAPEPORT G, Smith E, Gilbert A, Catchpole A, et al
SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMp2106970.
PubMed

CHU VT, Yousaf AR, Chang K, Schwartz NG, et al
Household Transmission of SARS-CoV-2 from Children and Adolescents.
N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMc2031915.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
N Engl J Med. 2021;385:e18.
PubMed

NORMARK J, Vikstrom L, Gwon YD, Persson IL, et al
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2110716.
PubMed

DOUGAN M, Nirula A, Azizad M, Mocherla B, et al
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMoa2102685.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: How Well Are Covid-19 Vaccines Working?
N Engl J Med. 2021;385:e15.
PubMed

EDARA VV, Pinsky BA, Suthar MS, Lai L, et al
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2107799.
PubMed

BRINKLEY-RUBINSTEIN L, Peterson M, Martin R, Chan P, et al
Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.
N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2108479.
PubMed

JARA A, Undurraga EA, Gonzalez C, Paredes F, et al
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.
N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMoa2107715.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Another New Covid-19 Vaccine.
N Engl J Med. 2021;385:e13.
PubMed

SON MBF, Murray N, Friedman K, Young CC, et al
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
N Engl J Med. 2021;385:23-34.
PubMed Abstract available

MCARDLE AJ, Vito O, Patel H, Seaby EG, et al
Treatment of Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2021;385:11-22.
PubMed Abstract available

June 2021

THOMPSON MG, Burgess JL, Naleway AL, Tyner H, et al
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107058.
PubMed Abstract available

HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107659.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New mRNA Vaccine.
N Engl J Med. 2021;384:e109.
PubMed

KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
SARS-CoV-2 Variants and Vaccines.
N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMsr2105280.
PubMed Abstract available

KAMAR N, Abravanel F, Marion O, Couat C, et al
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2108861.
PubMed

HARRIS RJ, Hall JA, Zaidi A, Andrews NJ, et al
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2107717.
PubMed

KOENIG PA, Schmidt FI
Spike D614G - A Candidate Vaccine Antigen Against Covid-19.
N Engl J Med. 2021;384:2349-2351.
PubMed

RILEY LE
mRNA Covid-19 Vaccines in Pregnant Women.
N Engl J Med. 2021;384:2342-2343.
PubMed

JAGSI R, Fuentes-Afflick E, Higginbotham E
Promoting Equity for Women in Medicine - Seizing a Disruptive Opportunity.
N Engl J Med. 2021;384:2265-2267.
PubMed

HIBBERT KA, Goiffon RJ, Fogerty AE
Case 18-2021: An 81-Year-Old Man with Cough, Fever, and Shortness of Breath.
N Engl J Med. 2021;384:2332-2340.
PubMed

ESSEX R, Weldon SM
Health Care Worker Strikes and the Covid Pandemic.
N Engl J Med. 2021;384:e93.
PubMed

RUBIN EJ, Baden LR, Ingelfinger JR, Morrissey S, et al
Audio Interview: Covid-19 in Children.
N Engl J Med. 2021;384:e108.
PubMed

VANDEBOSCH A, Sadoff J, Douoguih M
Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply.
N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
PubMed

HEININGER U
Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
PubMed

SAMARAKOON U, Alvarez-Arango S, Blumenthal KG
Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color.
N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMc2108620.
PubMed

BECKER SJ, Taylor J, Sharfstein JM
Identifying and Tracking SARS-CoV-2 Variants - A Challenge and an Opportunity.
N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMp2103859.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Vaccinating Children.
N Engl J Med. 2021;384:e103.
PubMed

BLACHERE NE, Hacisuleyman E, Darnell RB
Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.
N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
PubMed

RANA K, Mohindra R, Pinnaka L
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
PubMed

NIXON DF, Ndhlovu LC
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
PubMed

May 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Protecting the Immunosuppressed against Covid-19.
N Engl J Med. 2021;384:e88.
PubMed

BURRIS S, Anderson ED, Wagenaar AC
The "Legal Epidemiology" of Pandemic Control.
N Engl J Med. 2021;384:1973-1975.
PubMed

FRENCK RW JR, Klein NP, Kitchin N, Gurtman A, et al
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
N Engl J Med. 2021 May 27. doi: 10.1056/NEJMoa2107456.
PubMed Abstract available

VOLPP KG, Cannuscio CC
Incentives for Immunity - Strategies for Increasing Covid-19 Vaccine Uptake.
N Engl J Med. 2021 May 26. doi: 10.1056/NEJMp2107719.
PubMed

SPARROW AK, Brosseau LM, Harrison RJ, Osterholm MT, et al
Protecting Olympic Participants from Covid-19 - The Urgent Need for a Risk-Management Approach.
N Engl J Med. 2021 May 25. doi: 10.1056/NEJMp2108567.
PubMed

RUBIN EJ, Baden LR, Drazen JM, Taichman DB, et al
Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
N Engl J Med. 2021;384:e89.
PubMed

O'CONNELL J, O'Keeffe DT
Contact Tracing for Covid-19 - A Digital Inoculation against Future Pandemics.
N Engl J Med. 2021 May 19. doi: 10.1056/NEJMp2102256.
PubMed

WHITE EM, Yang X, Blackman C, Feifer RA, et al
Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.
N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2104849.
PubMed

RUBIN EJ, Baden LR, Gray GE, Morrissey S, et al
Audio Interview: Vaccination and Variants in the U.S. and South Africa.
N Engl J Med. 2021;384:e85.
PubMed

RODRIGUEZ-HERNANDEZ M, Pilato TC, Yerdon KA, Kysel IM, et al
Detained.
N Engl J Med. 2021;384:1785-1787.
PubMed

WAPPNER D, Bergel E, Polack FP
Plasma Therapy to Prevent Severe Covid-19 in Older Adults. Reply.
N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
PubMed

RAGUSA M, Tortosa F, Izcovich A
Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
PubMed

KLAMT F, Parsons RB, Jones MH
Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2104747.
PubMed

KEEHNER J, Abeles SR, Torriani FJ
More on SARS-CoV-2 Infection after Vaccination in Health Care Workers. Reply.
N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2106004.
PubMed

LIU Y, Liu J, Xia H, Zhang X, et al
BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
N Engl J Med. 2021 May 12. doi: 10.1056/NEJMc2106083.
PubMed

SCALES D, Gorman J, Jamieson KH
The Covid-19 Infodemic - Applying the Epidemiologic Model to Counter Misinformation.
N Engl J Med. 2021 May 12. doi: 10.1056/NEJMp2103798.
PubMed

RUBIN EJ, Baden LR, Udwadia ZF, Morrissey S, et al
Audio Interview: India's Covid-19 Crisis.
N Engl J Med. 2021;384:e84.
PubMed

SALWA J, Robertson C
Designing an Independent Public Health Agency.
N Engl J Med. 2021;384:1684-1687.
PubMed

NEUZIL KM
Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control.
N Engl J Med. 2021 May 5. doi: 10.1056/NEJMe2103931.
PubMed

SHINDE V, Bhikha S, Hoosain Z, Archary M, et al
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med. 2021 May 5. doi: 10.1056/NEJMoa2103055.
PubMed Abstract available

RATZAN S, Schneider EC, Hatch H, Cacchione J, et al
Missing the Point - How Primary Care Can Overcome Covid-19 Vaccine "Hesitancy".
N Engl J Med. 2021 May 5. doi: 10.1056/NEJMp2106137.
PubMed

ABU-RADDAD LJ, Chemaitelly H, Butt AA
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
N Engl J Med. 2021 May 5. doi: 10.1056/NEJMc2104974.
PubMed

April 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions.
N Engl J Med. 2021;384:e77.
PubMed

KADAKIA KT, Beckman AL, Ross JS, Krumholz HM, et al
Leveraging Open Science to Accelerate Research.
N Engl J Med. 2021;384:e61.
PubMed

GOLDFARB JL, Kreps S, Brownstein JS, Kriner DL, et al
Beyond the First Dose - Covid-19 Vaccine Follow-through and Continued Protective Measures.
N Engl J Med. 2021 Apr 28. doi: 10.1056/NEJMp2104527.
PubMed

FAJGENBAUM DC, June CH
Cytokine Storm. Reply.
N Engl J Med. 2021;384:e59.
PubMed

MUDD PA, Crawford JC, Thomas PG
Cytokine Storm.
N Engl J Med. 2021;384:e59.
PubMed

SUPADY A, Bode C, Duerschmied D
Cytokine Storm.
N Engl J Med. 2021;384:e59.
PubMed

GAESTEL M, Nebreda AR, Yaffe MB
Cytokine Storm.
N Engl J Med. 2021;384:e59.
PubMed

RUBIN EJ, Baden LR, Walensky RP, Morrissey S, et al
Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
N Engl J Med. 2021;384:e73.
PubMed

DODD LE, Freidlin B, Korn EL
Platform Trials - Beware the Noncomparable Control Group.
N Engl J Med. 2021;384:1572-1573.
PubMed

CANELLI R, Shrestha GS, Ortega R
Emergency Intubation in Covid-19. Reply.
N Engl J Med. 2021;384.
PubMed

PATEL J, Janapala RN, Pourmand A
Emergency Intubation in Covid-19.
N Engl J Med. 2021;384.
PubMed

SELLERS WFS
Emergency Intubation in Covid-19.
N Engl J Med. 2021;384.
PubMed

HERZOG N, Giacardi C, Danguy des Deserts M
Emergency Intubation in Covid-19.
N Engl J Med. 2021;384.
PubMed

BARDA N, Dagan N, Balicer RD
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
N Engl J Med. 2021;384.
PubMed

ROEST S, Hoek RAS, Manintveld OC
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
N Engl J Med. 2021;384.
PubMed

BAECK M, Marot L, Belkhir L
Delayed Large Local Reactions to mRNA Vaccines.
N Engl J Med. 2021 Apr 21. pii: 10.1056/NEJMc2104751.
PubMed

SADOFF J, Gray G, Vandebosch A, Cardenas V, et al
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2101544.
PubMed Abstract available

HACISULEYMAN E, Hale C, Saito Y, Blachere NE, et al
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2105000.
PubMed Abstract available

CINES DB, Bussel JB
SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMe2106315.
PubMed

SCULLY M, Singh D, Lown R, Poles A, et al
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMoa2105385.
PubMed Abstract available

MECKLAI K, Smith N, Stern AD, Kramer DB, et al
Remote Patient Monitoring - Overdue or Overused?
N Engl J Med. 2021;384:1384-1386.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Vaccine Successes and Vaccine Adverse Events.
N Engl J Med. 2021;384:e70.
PubMed

LIU Y, Liu J, Xia H, Zhang X, et al
Neutralizing Activity of BNT162b2-Elicited Serum.
N Engl J Med. 2021;384:1466-1468.
PubMed

ANICHINI G, Terrosi C, Gandolfo C, Gori Savellini G, et al
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2103825.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Antibody Responses to Natural Infection and Vaccination.
N Engl J Med. 2021;384:e65.
PubMed

SASISEKHARAN R
Preparing for the Future - Nanobodies for Covid-19?
N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMcibr2101205.
PubMed

MOYO-GWETE T, Madzivhandila M, Makhado Z, Ayres F, et al
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).
N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104192.
PubMed

LUSTIG Y, Nemet I, Kliker L, Zuckerman N, et al
Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104036.
PubMed

SHEN X, Tang H, Pajon R, Smith G, et al
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2103740.
PubMed

KIM MC, Park MS, Chung JW
Viable SARS-CoV-2 Shedding. Reply.
N Engl J Med. 2021;384.
PubMed

ROMANO CM, Felix AC, Pannuti CS
Viable SARS-CoV-2 Shedding.
N Engl J Med. 2021;384.
PubMed

DORIA-ROSE N, Suthar MS, Makowski M, O'Connell S, et al
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103916.
PubMed

WANG GL, Wang ZY, Duan LJ, Meng QC, et al
Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103022.
PubMed

ELIAS C, Nkengasong JN, Qadri F
Emerging Infectious Diseases - Learning from the Past and Looking to the Future.
N Engl J Med. 2021;384:1181-1184.
PubMed

RUBIN EJ, Baden LR, Del Rio C, Akusobi C, et al
Audio Interview: Delivering Covid-19 Vaccines to Minority Communities.
N Engl J Med. 2021;384:e60.
PubMed

March 2021

QUINN SC, Andrasik MP
Addressing Vaccine Hesitancy in BIPOC Communities - Toward Trustworthiness, Partnership, and Reciprocity.
N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103104.
PubMed

NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
PubMed

HALL MA, Studdert DM
"Vaccine Passport" Certification - Policy and Ethical Considerations.
N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2104289.
PubMed

RUBIN EJ, Baden LR, Brandt AM, Morrissey S, et al
Audio Interview: What Earlier Epidemics Teach Us about Covid-19.
N Engl J Med. 2021;384:e55.
PubMed

KADIRE SR, Fabre V, Wenzel RP
Doctor, How Long Should I Isolate?
N Engl J Med. 2021;384:e47.
PubMed

ONI-ORISAN A, Mavura Y, Banda Y, Thornton TA, et al
Embracing Genetic Diversity to Improve Black Health.
N Engl J Med. 2021;384:1163-1167.
PubMed

ABDOOL KARIM SS, de Oliveira T
New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
N Engl J Med. 2021 Mar 24. doi: 10.1056/NEJMc2100362.
PubMed

ARMSTRONG K
Covid-19 and the Investigator Pipeline.
N Engl J Med. 2021 Mar 24. doi: 10.1056/NEJMp2100086.
PubMed

KEEHNER J, Horton LE, Pfeffer MA, Longhurst CA, et al
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.
N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101927.
PubMed

BENENSON S, Oster Y, Cohen MJ, Nir-Paz R, et al
BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.
N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101951.
PubMed

DANIEL W, Nivet M, Warner J, Podolsky DK, et al
Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center.
N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2102153.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses.
N Engl J Med. 2021;384:e53.
PubMed

WU K, Werner AP, Koch M, Choi A, et al
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
N Engl J Med. 2021 Mar 17. doi: 10.1056/NEJMc2102179.
PubMed

KRUTIKOV M, Hayward A, Shallcross L
Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England.
N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMc2035906.
PubMed

MADHI SA, Baillie V, Cutland CL, Voysey M, et al
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMoa2102214.
PubMed Abstract available

CARTER S
Breathless.
N Engl J Med. 2021;384:891-893.
PubMed

RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
N Engl J Med. 2021;384:e48.
PubMed

POOLE MK, Fleischhacker SE, Bleich SN
Addressing Child Hunger When School Is Closed - Considerations during the Pandemic and Beyond.
N Engl J Med. 2021;384:e35.
PubMed

KRAMMER F, Srivastava K, Alshammary H, Amoako AA, et al
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMc2101667.
PubMed

GORALNICK E, Kaufmann C, Gawande AA
Mass-Vaccination Sites - An Essential Innovation to Curb the Covid-19 Pandemic.
N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMp2102535.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment.
N Engl J Med. 2021;384:e46.
PubMed

GOLETTI D, Cantini F
Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.
N Engl J Med. 2021;384:867-869.
PubMed

BLUMENTHAL KG, Freeman EE, Saff RR, Robinson LB, et al
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.
N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMc2102131.
PubMed

STONE JH
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.
N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
PubMed

SALAMA C, Mohan SV
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. Reply.
N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
PubMed

LUNDH A
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med. 2021 Mar 3. pii: 10.1056/NEJMc2100217.
PubMed

STEELFISHER GK, Blendon RJ, Caporello H
An Uncertain Public - Encouraging Acceptance of Covid-19 Vaccines.
N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100351.
PubMed

BARSKY BA, Reinhart E, Farmer P, Keshavjee S, et al
Vaccination plus Decarceration - Stopping Covid-19 in Jails and Prisons.
N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100609.
PubMed

KRAMER DB, Opel DJ, Parasidis E, Mello MM, et al
Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines.
N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2102146.
PubMed

LUDVIGSSON JF
Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden. Reply.
N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
PubMed

BESANCON L, Steadson D, Flahault A
Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
PubMed

TAKEFUJI Y
Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
N Engl J Med. 2021 Mar 1. pii: 10.1056/NEJMc2101280.
PubMed

February 2021

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination.
N Engl J Med. 2021;384:e40.
PubMed

NORMAND ST
The RECOVERY Platform.
N Engl J Med. 2021;384:757-758.
PubMed

LANE HC, Fauci AS
Research in the Context of a Pandemic.
N Engl J Med. 2021;384:755-757.
PubMed

MEHROTRA A, Nimgaonkar A, Richman B
Telemedicine and Medical Licensure - Potential Paths for Reform.
N Engl J Med. 2021;384:687-690.
PubMed

VAIS S
The Inequity of Isolation.
N Engl J Med. 2021;384:690-691.
PubMed

ROSAS IO, Brau N, Waters M, Go RC, et al
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMoa2028700.
PubMed Abstract available

GORDON AC, Mouncey PR, Al-Beidh F, Rowan KM, et al
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMoa2100433.
PubMed Abstract available

RUBIN EJ, Longo DL, Baden LR
Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup.
N Engl J Med. 2021 Feb 25. doi: 10.1056/NEJMe2103108.
PubMed

DAGAN N, Barda N, Kepten E, Miron O, et al
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2101765.
PubMed Abstract available

RUBIN EJ, Baden LR, Farrar JJ, Morrissey S, et al
Audio Interview: Viral Variants and Covid-19.
N Engl J Med. 2021;384:e38.
PubMed

SHRESTHA GS, Shrestha N, Lamsal R, Pradhan S, et al
Emergency Intubation in Covid-19.
N Engl J Med. 2021;384:e20.
PubMed

KADIRE SR, Wachter RM, Lurie N
Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination.
N Engl J Med. 2021 Feb 17. doi: 10.1056/NEJMclde2101987.
PubMed

ABSALON J, Koury K, Gruber WC
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
N Engl J Med. 2021;384.
PubMed

WANG X
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2021;384.
PubMed

VERGNES JN
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2021;384.
PubMed

SKOWRONSKI DM, De Serres G
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2021;384.
PubMed

ROSENBAUM L
Escaping Catch-22 - Overcoming Covid Vaccine Hesitancy.
N Engl J Med. 2021 Feb 12. doi: 10.1056/NEJMms2101220.
PubMed

HARRINGTON DP, Baden LR, Hogan JW
A Large, Simple Trial Leading to Complex Questions.
N Engl J Med. 2021;384:576-577.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing?
N Engl J Med. 2021;384:e32.
PubMed

HORBY P, White NJ, Landray MJ
Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply.
N Engl J Med. 2021;384.
PubMed

LACOUT A, Perronne C, Lounnas V
Hydroxychloroquine in Hospitalized Patients with Covid-19.
N Engl J Med. 2021;384.
PubMed

CASTELLS MC, Phillips EJ
Maintaining Safety with SARS-CoV-2 Vaccines. Reply.
N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
PubMed

ROLLA G, Brussino L, Badiu I
Maintaining Safety with SARS-CoV-2 Vaccines.
N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
PubMed

KASPER MR, Geibe JR
An Outbreak of Covid-19 on an Aircraft Carrier. Reply.
N Engl J Med. 2021;384.
PubMed

BYLICKI O, Paleiron N, Janvier F
An Outbreak of Covid-19 on an Aircraft Carrier.
N Engl J Med. 2021;384.
PubMed

RUBIN EJ, Baden LR, Northam RS, Morrissey S, et al
Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam.
N Engl J Med. 2021;384:e25.
PubMed

WYLLIE AL, Vogels CBF, Grubaugh ND
Saliva for Detection of SARS-CoV-2. Reply.
N Engl J Med. 2021;384.
PubMed

MARKEWITZ RDH, Wandinger KP, Junker R
Saliva for Detection of SARS-CoV-2.
N Engl J Med. 2021;384.
PubMed

LUNDGREN JD, Lane HC, Neaton JD
Monoclonal Antibody for Patients with Covid-19. Reply.
N Engl J Med. 2021 Feb 3. pii: 10.1056/NEJMc2100221.
PubMed

JAWORSKI JP
Monoclonal Antibody for Patients with Covid-19.
N Engl J Med. 2021 Feb 3. pii: 10.1056/NEJMc2100221.
PubMed

January 2021

RUBIN EJ, Baden LR, Fauci AS, Morrissey S, et al
Audio Interview: A Covid-19 Conversation with Anthony Fauci.
N Engl J Med. 2021;384:e22.
PubMed

HEATON PM
The Covid-19 Vaccine-Development Multiverse. Reply.
N Engl J Med. 2021;384.
PubMed

KOJIMA N, Turner I, Klausner JD
The Covid-19 Vaccine-Development Multiverse.
N Engl J Med. 2021;384.
PubMed

KIM MC, Cui C, Shin KR, Bae JY, et al
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19.
N Engl J Med. 2021 Jan 27. doi: 10.1056/NEJMc2027040.
PubMed

LEE TH, Chen AH
Last-Mile Logistics of Covid Vaccination - The Role of Health Care Organizations.
N Engl J Med. 2021 Jan 27. doi: 10.1056/NEJMp2100574.
PubMed

COHEN MS
Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection.
N Engl J Med. 2021;384:289-291.
PubMed

BOTTI-LODOVICO Y, Rosenberg E, Sabeti PC
Testing in a Pandemic - Improving Access, Coordination, and Prioritization.
N Engl J Med. 2021;384:197-199.
PubMed

RUBIN EJ, Baden LR, Nottage K, O'Connell J, et al
Audio Interview: An International Look at Covid-19.
N Engl J Med. 2021;384:e19.
PubMed

PARMET WE
Roman Catholic Diocese of Brooklyn v. Cuomo - The Supreme Court and Pandemic Controls.
N Engl J Med. 2021;384:199-201.
PubMed

KLASS P, Ratner AJ
Vaccinating Children against Covid-19 - The Lessons of Measles.
N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034765.
PubMed

VAN TASSEL K, Shachar C, Hoffman S
Covid-19 Vaccine Injuries - Preventing Inequities in Compensation.
N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034438.
PubMed

RUBIN EJ, Baden LR, Abdool Karim SS, Morrissey S, et al
Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
N Engl J Med. 2021;384:e14.
PubMed

KATZ LM
(A Little) Clarity on Convalescent Plasma for Covid-19.
N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMe2035678.
PubMed

JOYNER MJ, Carter RE, Senefeld JW, Klassen SA, et al
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2031893.
PubMed Abstract available

SADOFF J, Le Gars M, Shukarev G, Heerwegh D, et al
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2034201.
PubMed Abstract available

RUBIN EJ, Baden LR, Lee TH, Morrissey S, et al
Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
N Engl J Med. 2021;384:e13.
PubMed

LIBSTER R, Perez Marc G, Wappner D, Coviello S, et al
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMoa2033700.
PubMed Abstract available

LUDVIGSSON JF, Engerstrom L, Nordenhall C, Larsson E, et al
Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden.
N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMc2026670.
PubMed

WOOD S, Schulman K
Beyond Politics - Promoting Covid-19 Vaccination in the United States.
N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMms2033790.
PubMed

December 2020

MILLER SE
Visualization of SARS-CoV-2 in the Lung.
N Engl J Med. 2020;383:2689.
PubMed

ACKERMANN M, Mentzer SJ, Jonigk D
Visualization of SARS-CoV-2 in the Lung. Reply.
N Engl J Med. 2020;383:2689-2690.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
N Engl J Med. 2020;383:e147.
PubMed

PERRIN JM, Kenney GM, Rosenbaum S
Medicaid and Child Health Equity.
N Engl J Med. 2020;383:2595-2598.
PubMed

CHATTERJEE P, Sommers BD, Joynt Maddox KE
Essential but Undefined - Reimagining How Policymakers Identify Safety-Net Hospitals.
N Engl J Med. 2020;383:2593-2595.
PubMed

RUBIN D, Chan-Tack K, Farley J, Sherwat A, et al
FDA Approval of Remdesivir - A Step in the Right Direction.
N Engl J Med. 2020;383:2598-2600.
PubMed

LEITER RE
Reentry.
N Engl J Med. 2020;383:e141.
PubMed

BADEN LR, Solomon CG, Greene MF, D'Agostino RB, et al
The FDA and the Importance of Trust.
N Engl J Med. 2020;383:e148.
PubMed

NIRULA A, Shen L, Skovronsky DM
Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. Reply.
N Engl J Med. 2020;384.
PubMed

CASADEVALL A, Joyner MJ, Pirofski LA
Neutralizing Antibody LY-CoV555 for Outpatient Covid-19.
N Engl J Med. 2020;384.
PubMed

FOPPIANO PALACIOS C, Travassos MA
Vaccinating Detained Migrants against SARS-CoV-2 - Preventing Another Tragedy.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035416.
PubMed

BAROCAS JA
Business Not as Usual - Covid-19 Vaccination in Persons with Substance Use Disorders.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035709.
PubMed

BADEN LR, El Sahly HM, Essink B, Kotloff K, et al
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMoa2035389.
PubMed Abstract available

LEE MH, Perl DP, Nair G, Li W, et al
Microvascular Injury in the Brains of Patients with Covid-19.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMc2033369.
PubMed

HAYNES BF
A New Vaccine to Battle Covid-19.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMe2035557.
PubMed

CASTELLS MC, Phillips EJ
Maintaining Safety with SARS-CoV-2 Vaccines.
N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMra2035343.
PubMed

HELLER HM, Gonzalez RG, Edlow BL, Ard KL, et al
Case 40-2020: A 24-Year-Old Man with Headache and Covid-19.
N Engl J Med. 2020;383:2572-2580.
PubMed

MAITRA A
Holding Up.
N Engl J Med. 2020;383:2498-2499.
PubMed

RITTENBERG E
Sewing Masks - Resilience in the Face of Covid.
N Engl J Med. 2020;383:2497-2498.
PubMed

TAMBYRAJA AL
New Order, New Hope.
N Engl J Med. 2020;383:2495-2496.
PubMed

LUMLEY SF, O'Donnell D, Stoesser NE, Matthews PC, et al
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
N Engl J Med. 2020 Dec 23. doi: 10.1056/NEJMoa2034545.
PubMed Abstract available

STONE JH, Horick NK, Healy BC
Tocilizumab in Covid-19. Reply.
N Engl J Med. 2020;384.
PubMed

LEAF DE, Gupta S, Wang W
Tocilizumab in Covid-19.
N Engl J Med. 2020;384.
PubMed

LUNDGREN JD, Grund B, Barkauskas CE, Holland TL, et al
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
N Engl J Med. 2020 Dec 22. doi: 10.1056/NEJMoa2033130.
PubMed Abstract available

CHASTAIN DB, Henao-Martinez AF, Young HN
Racial Disproportionality in Covid Clinical Trials. Reply.
N Engl J Med. 2020;383:2488-2490.
PubMed

TOMASHEK KM, Mehta AK, Hynes NA
Racial Disproportionality in Covid Clinical Trials.
N Engl J Med. 2020;383:2487-2488.
PubMed

GOLDMAN JD, Osinusi A, Marty FM
Racial Disproportionality in Covid Clinical Trials.
N Engl J Med. 2020;383:2486-2487.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 Vaccine Fundamentals.
N Engl J Med. 2020;383:e146.
PubMed

HUNTER DJ
Trying to "Protect the NHS" in the United Kingdom.
N Engl J Med. 2020;383:e136.
PubMed

SALAMA C, Han J, Yau L, Reiss WG, et al
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med. 2020 Dec 17. doi: 10.1056/NEJMoa2030340.
PubMed Abstract available

WEINREICH DM, Sivapalasingam S, Norton T, Ali S, et al
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
N Engl J Med. 2020 Dec 17. doi: 10.1056/NEJMoa2035002.
PubMed Abstract available

BARIC RS
Emergence of a Highly Fit SARS-CoV-2 Variant.
N Engl J Med. 2020 Dec 16. doi: 10.1056/NEJMcibr2032888.
PubMed

KALIL AC, Patterson TF, Mehta AK, Tomashek KM, et al
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med. 2020 Dec 11. doi: 10.1056/NEJMoa2031994.
PubMed Abstract available

RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
N Engl J Med. 2020;383:e143.
PubMed

HUANG E, Jordan SC
Tocilizumab for Covid-19 - The Ongoing Search for Effective Therapies.
N Engl J Med. 2020;383:2387-2388.
PubMed

LEICK MB
Telephone.
N Engl J Med. 2020;383:2304-2305.
PubMed

POLACK FP, Thomas SJ, Kitchin N, Absalon J, et al
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMoa2034577.
PubMed Abstract available

RUBIN EJ, Longo DL
SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention.
N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMe2034717.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Caring for Hospitalized Patients with Covid-19.
N Engl J Med. 2020;383:e140.
PubMed

FAJGENBAUM DC, June CH
Cytokine Storm.
N Engl J Med. 2020;383:2255-2273.
PubMed

LAHEY T
The Bottom of the Health Care Rationing Iceberg.
N Engl J Med. 2020;383:2200-2201.
PubMed

XING Y, Wong GWK, Ni W, Hu X, et al
Rapid Response to an Outbreak in Qingdao, China.
N Engl J Med. 2020;383:e129.
PubMed

WIDGE AT, Rouphael NG, Jackson LA, Anderson EJ, et al
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
N Engl J Med. 2020 Dec 3. doi: 10.1056/NEJMc2032195.
PubMed

CAVALCANTI AB, Berwanger O, Zampieri FG
Hydroxychloroquine with or without Azithromycin in Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

CHOUDHARY R, Bohra GK, Kumar D
Hydroxychloroquine with or without Azithromycin in Covid-19.
N Engl J Med. 2020;383.
PubMed

KEANE MJ
Hydroxychloroquine with or without Azithromycin in Covid-19.
N Engl J Med. 2020;383.
PubMed

PAN H, Peto R, Henao-Restrepo AM, Preziosi MP, et al
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMoa2023184.
PubMed Abstract available

AYDILLO T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, et al
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.
N Engl J Med. 2020 Dec 1. doi: 10.1056/NEJMc2031670.
PubMed

November 2020

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: New Studies of Covid-19 Transmission.
N Engl J Med. 2020;383:e138.
PubMed

KATZ DH, Wilson JG, Gerszten RE
Mining a GWAS of Severe Covid-19.
N Engl J Med. 2020;383.
PubMed

KARIM M, Ghoussaini M, Dunham I
Mining a GWAS of Severe Covid-19.
N Engl J Med. 2020;383.
PubMed

KENNEDY BS, Richeson RP, Houde AJ
Risk Factors for SARS-CoV-2 in a Statewide Correctional System.
N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMc2029354.
PubMed

MITJA O, Corbacho-Monne M, Ubals M, Alemany A, et al
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2021801.
PubMed Abstract available

SIMONOVICH VA, Burgos Pratx LD, Scibona P, Beruto MV, et al
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.
N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2031304.
PubMed Abstract available

MANZANO GS, Woods JK, Amato AA
Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
N Engl J Med. 2020 Nov 20. doi: 10.1056/NEJMc2031085.
PubMed

RUBIN EJ, Baden LR, Haug CJ, Morrissey S, et al
Audio Interview: Covid-19 in Europe and New Information on Vaccines.
N Engl J Med. 2020;383:e134.
PubMed

MALINA S, Warbelow S, Radix AE
Two Steps Back - Rescinding Transgender Health Protections in Risky Times.
N Engl J Med. 2020;383:e116.
PubMed

RUBIN EJ, Baden LR, Woodcock J, Morrissey S, et al
Audio Interview: An Update from Operation Warp Speed.
N Engl J Med. 2020;383:e127.
PubMed

CHOI B, Choudhary MC, Regan J, Sparks JA, et al
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMc2031364.
PubMed

MICHAEL NL
SARS-CoV-2 in the U.S. Military - Lessons for Civil Society.
N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMe2032179.
PubMed

LETIZIA AG, Ramos I, Obla A, Goforth C, et al
SARS-CoV-2 Transmission among Marine Recruits during Quarantine.
N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMoa2029717.
PubMed Abstract available

KASPER MR, Geibe JR, Sears CL, Riegodedios AJ, et al
An Outbreak of Covid-19 on an Aircraft Carrier.
N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMoa2019375.
PubMed Abstract available

DOLIN R, Hirsch MS
Remdesivir - An Important First Step.
N Engl J Med. 2020;383:1886-1887.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
N Engl J Med. 2020;383:e123.
PubMed

MATIAS WR, Vaidya A, Brigl M, Bebell LM, et al
A Patient with Fever and Dyspnea.
N Engl J Med. 2020;383:e111.
PubMed

GUDBJARTSSON DF, Stefansson K
Early Spread of SARS-CoV-2 in the Icelandic Population. Reply.
N Engl J Med. 2020;383.
PubMed

COWIE BC, MacLachlan JH
Early Spread of SARS-CoV-2 in the Icelandic Population.
N Engl J Med. 2020;383.
PubMed

October 2020

LEVIN M
Multisystem Inflammatory Syndrome in Children in the United States. Reply.
N Engl J Med. 2020;383:1795-1796.
PubMed

FELDSTEIN LR, Rose EB, Randolph AG
Multisystem Inflammatory Syndrome in Children in the United States. Reply.
N Engl J Med. 2020;383:1794-1795.
PubMed

ARDITI M, Bahar I
Multisystem Inflammatory Syndrome in Children in the United States.
N Engl J Med. 2020;383:1794.
PubMed

ALTER G, Seder R
The Power of Antibody-Based Surveillance.
N Engl J Med. 2020;383:1782-1784.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: A New Monoclonal Antibody for Covid-19.
N Engl J Med. 2020;383:e117.
PubMed

WU K, Smith CR, Lembcke BT, Ferreira TBD, et al
Elective Surgery during the Covid-19 Pandemic.
N Engl J Med. 2020;383:1787-1790.
PubMed

BLENDON RJ, Benson JM
Implications of the 2020 Election for U.S. Health Policy.
N Engl J Med. 2020;383:e105.
PubMed

CAHAN EM, Levine LB, Chin WW
The Human Touch - Addressing Health Care's Workforce Problem amid the Pandemic.
N Engl J Med. 2020;383:e102.
PubMed

DEFOREST A
The New Stability.
N Engl J Med. 2020;383:1708-1709.
PubMed

HALABI S, Heinrich A, Omer SB
No-Fault Compensation for Vaccine Injury - The Other Side of Equitable Access to Covid-19 Vaccines.
N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMp2030600.
PubMed

CHEN P, Nirula A, Heller B, Gottlieb RL, et al
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMoa2029849.
PubMed Abstract available

REYNOLDS HR, Adhikari S, Iturrate E
RAAS Inhibitors and Risk of Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

MANCIA G, Rea F, Corrao G
RAAS Inhibitors and Risk of Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

STRAUSS MH, Hall AS, Lavie CJ
RAAS Inhibitors and Risk of Covid-19.
N Engl J Med. 2020;383.
PubMed

ISLAM N, Khunti K, Chowell G
RAAS Inhibitors and Risk of Covid-19.
N Engl J Med. 2020;383.
PubMed

SRIRAM K, Loomba R, Insel PA
RAAS Inhibitors and Risk of Covid-19.
N Engl J Med. 2020;383.
PubMed

ANGELI F, Verdecchia P, Reboldi G
RAAS Inhibitors and Risk of Covid-19.
N Engl J Med. 2020;383.
PubMed

GANDHI M, Rutherford GW
Facial Masking for Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

BROSSEAU LM, Roy CJ, Osterholm MT
Facial Masking for Covid-19.
N Engl J Med. 2020;383.
PubMed

RASMUSSEN AL, Escandon K, Popescu SV
Facial Masking for Covid-19.
N Engl J Med. 2020;383.
PubMed

PLATTON S, Bowles L, Pasi KJ
Lupus Anticoagulant in Patients with Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

GOODING R, Myers B, Salta S
Lupus Anticoagulant in Patients with Covid-19.
N Engl J Med. 2020;383.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Tocilizumab and Covid-19.
N Engl J Med. 2020;383:e114.
PubMed

CHOWDHURY JF, Moores LK, Connors JM
Anticoagulation in Hospitalized Patients with Covid-19.
N Engl J Med. 2020;383:1675-1678.
PubMed

ROSENBAUM L
Tribal Truce - How Can We Bridge the Partisan Divide and Conquer Covid?
N Engl J Med. 2020;383:1682-1685.
PubMed

WILENSKY GR
Policy Lessons from Our Covid Experience.
N Engl J Med. 2020;383:e96.
PubMed

AGARWAL SD, Sommers BD
Insurance Coverage after Job Loss - The Importance of the ACA during the Covid-Associated Recession.
N Engl J Med. 2020;383:1603-1606.
PubMed

BELOT A, Levy-Bruhl D
Multisystem Inflammatory Syndrome in Children in the United States.
N Engl J Med. 2020;383.
PubMed

STRASSLE C, Jardas E, Ochoa J, Berkman BE, et al
Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2025955.
PubMed

STONE JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, et al
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMoa2028836.
PubMed Abstract available

RAFIEI Y, Mello MM
The Missing Piece - SARS-CoV-2 Testing and School Reopening.
N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2028209.
PubMed

KRAUSE PR, Gruber MF
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2031373.
PubMed

WARREN RC, Forrow L, Hodge DA Sr, Truog RD, et al
Trustworthiness before Trust - Covid-19 Vaccine Trials and the Black Community.
N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2030033.
PubMed

KASER A
Genetic Risk of Severe Covid-19.
N Engl J Med. 2020;383:1590-1591.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Vaccinology and Covid-19.
N Engl J Med. 2020;383:e109.
PubMed

GLIED S
Health Policy in a Biden Administration.
N Engl J Med. 2020;383:1501-1503.
PubMed

WALSH EE, Frenck RW Jr, Falsey AR, Kitchin N, et al
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMoa2027906.
PubMed Abstract available

SHAPIRO J, McDonald TB
Supporting Clinicians during Covid-19 and Beyond - Learning from Past Failures and Envisioning New Strategies.
N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMp2024834.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 and the President.
N Engl J Med. 2020;383:e104.
PubMed

Dying in a Leadership Vacuum.
N Engl J Med. 2020;383:1479-1480.
PubMed

HORBY P, Mafham M, Linsell L, Bell JL, et al
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
N Engl J Med. 2020 Oct 8. doi: 10.1056/NEJMoa2022926.
PubMed Abstract available

CELUM C, Barnabas R, Cohen MS, Collier A, et al
Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact.
N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2022269.
PubMed

PAGE KR, Flores-Miller A
Lessons We've Learned - Covid-19 and the Undocumented Latinx Community.
N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2024897.
PubMed

ROSENQUIST JN
The Stress of Bayesian Medicine - Uncomfortable Uncertainty in the Face of Covid-19.
N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2018857.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Covid-19 Testing and the Individual Physician.
N Engl J Med. 2020;383:e99.
PubMed

HATA SR
The Ritual of the Table.
N Engl J Med. 2020;383:1301-1303.
PubMed

September 2020

RASMUSSEN SA, Lyerly AD, Jamieson DJ
Delaying Pregnancy during a Public Health Crisis - Examining Public Health Recommendations for Covid-19 and Beyond.
N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2027940.
PubMed

MINA MJ, Parker R, Larremore DB
Rethinking Covid-19 Test Sensitivity - A Strategy for Containment.
N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2025631.
PubMed

ANDERSON EJ, Rouphael NG, Widge AT, Jackson LA, et al
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
N Engl J Med. 2020 Sep 29. doi: 10.1056/NEJMoa2028436.
PubMed Abstract available

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Eight Months of Action and Inaction against Covid-19.
N Engl J Med. 2020;383:e95.
PubMed

CHRISTIE A, Neatherlin JC, Nichol ST, Beach M, et al
Ebola Response Priorities in the Time of Covid-19.
N Engl J Med. 2020;383:1202-1204.
PubMed

CUNEO CN, Janeway H
From Icebox to Tinderbox - A View from the Southern Border.
N Engl J Med. 2020;383:e81.
PubMed

YANG OO, Ibarrondo FJ
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
N Engl J Med. 2020;383.
PubMed

KUTSUNA S, Asai Y, Matsunaga A
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
N Engl J Med. 2020;383.
PubMed

TERPOS E, Mentis A, Dimopoulos MA
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
N Engl J Med. 2020;383.
PubMed

BOLKE E, Matuschek C, Fischer JC
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
N Engl J Med. 2020;383.
PubMed

SCHWARTZ JL
Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2026393.
PubMed

PERETZ PJ, Islam N, Matiz LA
Community Health Workers and Covid-19 - Addressing Social Determinants of Health in Times of Crisis and Beyond.
N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2022641.
PubMed

RUBIN EJ, Baden LR, Morrissey S
Audio Interview: Operation Warp Speed and Covid-19 Therapeutics.
N Engl J Med. 2020;383:e92.
PubMed

FISHMAN JA, Roberts MB, Zhang EW, Kumar D, et al
Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation.
N Engl J Med. 2020;383:1168-1180.
PubMed

JOUNG J, Ladha A, Saito M, Kim NG, et al
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing.
N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMc2026172.
PubMed

EVANS ML, Lindauer M, Farrell ME
A Pandemic within a Pandemic - Intimate Partner Violence during Covid-19.
N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMp2024046.
PubMed

AVORN J, Kesselheim AS
Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.
N Engl J Med. 2020 Sep 15. doi: 10.1056/NEJMp2029479.
PubMed

SLAOUI M, Greene SE, Woodcock J
Bridging the Gap at Warp Speed - Delivering Options for Preventing and Treating Covid-19.
N Engl J Med. 2020 Sep 15. doi: 10.1056/NEJMp2028535.
PubMed

EVANS MK
Health Equity - Are We Finally on the Edge of a New Frontier?
N Engl J Med. 2020;383:997-999.
PubMed

GOLDHAMER MEJ, Pusic MV, Co JPT, Weinstein DF, et al
Can Covid Catalyze an Educational Transformation? Competency-Based Advancement in a Crisis.
N Engl J Med. 2020;383:1003-1005.
PubMed

SHUREN J, Stenzel T
Covid-19 Molecular Diagnostic Testing - Lessons Learned.
N Engl J Med. 2020 Sep 9. doi: 10.1056/NEJMp2023830.
PubMed

GANDHI M, Rutherford GW
Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine.
N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2026913.
PubMed

BLOOM BR, Nowak GJ, Orenstein W
"When Will We Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination.
N Engl J Med. 2020 Sep 8. doi: 10.1056/NEJMp2025331.
PubMed

KEECH C, Albert G, Cho I, Robertson A, et al
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
N Engl J Med. 2020 Sep 2. doi: 10.1056/NEJMoa2026920.
PubMed Abstract available

GUDBJARTSSON DF, Norddahl GL, Melsted P, Gunnarsdottir K, et al
Humoral Immune Response to SARS-CoV-2 in Iceland.
N Engl J Med. 2020 Sep 1. doi: 10.1056/NEJMoa2026116.
PubMed Abstract available

August 2020

WYLLIE AL, Fournier J, Casanovas-Massana A, Campbell M, et al
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.
N Engl J Med. 2020 Aug 28. doi: 10.1056/NEJMc2016359.
PubMed

SLAOUI M, Hepburn M
Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.
N Engl J Med. 2020 Aug 26. doi: 10.1056/NEJMp2027405.
PubMed

HORN DM, Haas JS
Covid-19 and the Mandate to Redefine Preventive Care.
N Engl J Med. 2020 Aug 12. doi: 10.1056/NEJMp2018749.
PubMed

STUDDERT DM, Hall MA, Mello MM
Partitioning the Curve - Interstate Travel Restrictions During the Covid-19 Pandemic.
N Engl J Med. 2020 Aug 5. doi: 10.1056/NEJMp2024274.
PubMed

July 2020

CORBETT KS, Flynn B, Foulds KE, Francica JR, et al
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
N Engl J Med. 2020 Jul 28. doi: 10.1056/NEJMoa2024671.
PubMed Abstract available

CAVALCANTI AB, Zampieri FG, Rosa RG, Azevedo LCP, et al
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
N Engl J Med. 2020 Jul 23. doi: 10.1056/NEJMoa2019014.
PubMed Abstract available

BERKOWITZ SA, Cene CW, Chatterjee A
Covid-19 and Health Equity - Time to Think Big.
N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMp2021209.
PubMed

EGEDE LE, Walker RJ
Structural Racism, Social Risk Factors, and Covid-19 - A Dangerous Convergence for Black Americans.
N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMp2023616.
PubMed

BLUMENTHAL D, Fowler EJ, Abrams M, Collins SR, et al
Covid-19 - Implications for the Health Care System.
N Engl J Med. 2020 Jul 22. doi: 10.1056/NEJMsb2021088.
PubMed

HORBY P, Lim WS, Emberson JR, Mafham M, et al
Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report.
N Engl J Med. 2020 Jul 17. doi: 10.1056/NEJMoa2021436.
PubMed Abstract available

NORTH CM, Dougan ML, Sacks CA
Improving Clinical Trial Enrollment - In the Covid-19 Era and Beyond.
N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMp2019989.
PubMed

JACKSON LA, Anderson EJ, Rouphael NG, Roberts PC, et al
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
N Engl J Med. 2020 Jul 14. doi: 10.1056/NEJMoa2022483.
PubMed Abstract available

HEATON PM
The Covid-19 Vaccine-Development Multiverse.
N Engl J Med. 2020 Jul 14. doi: 10.1056/NEJMe2025111.
PubMed

June 2020

MELLO MM, Silverman RD, Omer SB
Ensuring Uptake of Vaccines against SARS-CoV-2.
N Engl J Med. 2020 Jun 26. doi: 10.1056/NEJMp2020926.
PubMed

ELLINGHAUS D, Degenhardt F, Bujanda L, Buti M, et al
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
N Engl J Med. 2020 Jun 17. doi: 10.1056/NEJMoa2020283.
PubMed Abstract available

May 2020

GOLDMAN JD, Lye DCB, Hui DS, Marks KM, et al
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
N Engl J Med. 2020 May 27. doi: 10.1056/NEJMoa2015301.
PubMed Abstract available

BEIGEL JH, Tomashek KM, Dodd LE, Mehta AK, et al
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
N Engl J Med. 2020 May 22. doi: 10.1056/NEJMoa2007764.
PubMed Abstract available

BERLIN DA, Gulick RM, Martinez FJ
Severe Covid-19.
N Engl J Med. 2020 May 15. doi: 10.1056/NEJMcp2009575.
PubMed

April 2020

GANDHI RT, Lynch JB, Del Rio C
Mild or Moderate Covid-19.
N Engl J Med. 2020 Apr 24. doi: 10.1056/NEJMcp2009249.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.